Welbilt (WBT) 10-Q 6 May 20 2020 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2020	May 04, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2020
Document Transition Report	false
Entity File Number	1-37548
Entity Registrant Name	Welbilt, Inc.
Entity Central Index Key	0001650962
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-4625716
Entity Address, Address Line One	2227 Welbilt Boulevard
Entity Address, City or Town	New Port Richey
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	34655
City Area Code	727
Local Phone Number	375-7010
Title of 12(b) Security	Common stock, $0.01 par value
Trading Symbol	WBT
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		141,498,896

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Net sales	$ 328.9	$ 375.3
Cost of sales	214.1	248.8
Gross profit	114.8	126.5
Selling, general and administrative expenses	86.5	88.3
Amortization expense	9.7	9.5
Restructuring and other expenses	6.8	4.2
Loss from impairment and disposal of assets — net	11.2	0
Earnings from operations	0.6	24.5
Interest expense	21.3	24
Other (income) expense — net	(5.4)	3
Loss before income taxes	(15.3)	(2.5)
Income taxes	(0.2)	0.1
Net loss	$ (15.1)	$ (2.6)
Per share data:
Loss per share — Basic (in dollars per share)	$ (0.11)	$ (0.02)
Loss per share — Diluted (in dollars per share)	$ (0.11)	$ (0.02)
Weighted average shares outstanding — Basic (in shares)	141,430,614	140,612,213
Weighted average shares outstanding — Diluted (in shares)	141,430,614	140,612,213

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
Net loss	$ (15.1)	$ (2.6)
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments	(28.2)	0
Unrealized loss on derivatives	(0.4)	(1)
Employee pension and postretirement benefits	2	(1.2)
Total other comprehensive loss, net of tax	(26.6)	(2.2)
Comprehensive loss	$ (41.7)	$ (4.8)

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 148.5	$ 130.7
Accounts receivable, less allowance of $4.7 and $4.0, respectively	190	183.6
Inventories — net	200.9	186.4
Prepaids and other current assets	46.5	28.2
Total current assets	585.9	528.9
Property, plant and equipment — net	124.6	127.5
Operating lease right-of-use assets	38.3	39.9
Goodwill	929.7	933.1
Other intangible assets — net	481.9	507.7
Other non-current assets	24.6	28.2
Total assets	2,185	2,165.3
Current liabilities:
Trade accounts payable	113.8	104.4
Accrued expenses and other liabilities	141.3	192.4
Current portion of long-term debt and finance leases	1.9	1.2
Product warranties	31.9	33.3
Total current liabilities	288.9	331.3
Long-term debt and finance leases	1,506.1	1,403.1
Deferred income taxes	87.1	81.9
Pension and postretirement health liabilities	30.4	32.8
Operating lease liabilities	27.5	29.1
Other long-term liabilities	32	34.1
Total non-current liabilities	1,683.1	1,581
Commitments and contingencies (Note 12)
Total equity:
Common stock ($0.01 par value, 300,000,000 shares authorized, 141,487,527 shares and 141,213,995 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively)	1.4	1.4
Additional paid-in capital (deficit)	(28.9)	(31)
Retained earnings	309	324.5
Accumulated other comprehensive loss	(68.1)	(41.5)
Treasury stock, at cost, 61,712 shares and 58,935 shares, as of March 31, 2020 and December 31, 2019, respectively	(0.4)	(0.4)
Total equity	213	253
Total liabilities and equity	$ 2,185	$ 2,165.3

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Accounts receivable, allowances	$ 4.7	$ 4
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	300,000,000	300,000,000
Common stock, issued (in shares)	141,487,527	141,213,995
Common stock, outstanding (in shares)	141,487,527	141,213,995
Treasury stock (in shares)	61,712	58,935

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities
Net loss	$ (15.1)	$ (2.6)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation expense	5.2	4.9
Amortization of intangible assets	10	9.5
Amortization of debt issuance costs	1.1	1.2
Deferred income taxes	7	0
Stock-based compensation expense	1	2.9
Loss from impairment and disposal of assets	11.2	0
Pension settlement	0	1.2
Gain on remeasurement of debt and other realized foreign currency derivative	0	(0.8)
Changes in operating assets and liabilities:
Accounts receivable	(11.2)	(296.2)
Inventories	(19.1)	(14.5)
Other assets	(16.4)	(2)
Trade accounts payable	11.7	(26.7)
Other current and long-term liabilities	(57.9)	(33.9)
Net cash used in operating activities	(72.5)	(357)
Cash flows from investing activities
Cash receipts on beneficial interest in sold receivables	0	196
Capital expenditures	(5.6)	(4.8)
Other	(3.9)	0.2
Net cash (used in) provided by investing activities	(9.5)	191.4
Cash flows from financing activities
Proceeds from long-term debt	128	196.5
Repayments on long-term debt and finance leases	(23.3)	(32.8)
Repayment of short-term borrowings	0	(15)
Payment of contingent consideration	0	(0.8)
Exercises of stock options	1.1	0.6
Payments on tax withholdings for equity awards	(0.7)	(1.8)
Net cash provided by financing activities	105.1	146.7
Effect of exchange rate changes on cash	(5.3)	1
Net increase (decrease) in cash and cash equivalents and restricted cash	17.8	(17.9)
Balance at beginning of period	130.7	73.2
Balance at end of period	148.5	55.3
Supplemental disclosures of cash flow information:
Cash paid for income taxes, net of refunds	11.6	11
Cash paid for interest, net of related hedge settlements	31.4	23.3
Supplemental disclosures of non-cash activities:
Non-cash investing activity: Beneficial interest obtained in exchange for securitized receivables	0	238.6
Non-cash financing activity: Reassessments and modifications of right-of-use assets and lease liabilities and assets obtained through leasing arrangements	$ 5.5	$ 0.8

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Common Stock	Additional Paid-In Capital (Deficit)	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2018		140,252,693
Beginning balance at Dec. 31, 2018	$ 186.4	$ 1.4	$ (41.5)	$ 268.4	$ (41.6)	$ (0.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2.6)			(2.6)
Issuance of common stock, stock-based compensation plans (in shares)		604,511
Issuance of common stock, stock-based compensation plans	0.6		0.6
Stock-based compensation expense	2.9		2.9
Other comprehensive loss	(2.2)				(2.2)
Ending balance (in shares) at Mar. 31, 2019		140,857,204
Ending balance at Mar. 31, 2019	$ 185.3	$ 1.4	(38)	266	(43.8)	(0.3)
Beginning balance (in shares) at Dec. 31, 2019	141,213,995	141,213,995
Beginning balance at Dec. 31, 2019	$ 253	$ 1.4	(31)	324.5	(41.5)	(0.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(15.1)			(15.1)
Issuance of common stock, stock-based compensation plans (in shares)		273,532
Issuance of common stock, stock-based compensation plans	1.1		1.1
Stock-based compensation expense	1		1
Other comprehensive loss	$ (26.6)				(26.6)
Ending balance (in shares) at Mar. 31, 2020	141,487,527	141,487,527
Ending balance at Mar. 31, 2020	$ 213	$ 1.4	$ (28.9)	$ 309	$ (68.1)	$ (0.4)

Business and Organization

Business and Organization	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Business and Organization	Business and Organization Welbilt, Inc. ("Welbilt" or the "Company") is one of the world’s leading commercial foodservice equipment companies leveraging a full suite of equipment capable of storing, cooking, holding, displaying, dispensing and serving in both hot and cold foodservice categories. Headquartered in New Port Richey, Florida, the Company was incorporated in Delaware in 2015 and became publicly traded in March 2016 after a spin-off from its former parent. The Company operates 20 manufacturing facilities globally at which it designs, manufactures and supplies best-in-class equipment for the global commercial foodservice market, consisting of commercial and institutional foodservice operators including full-service restaurants, quick-service restaurant chains, hotels, resorts, cruise ships, caterers, supermarkets, convenience stores, hospitals, schools and other institutions. The Company sells its products through a global network of over 5,000 distributors, dealers, buying groups and manufacturers' representatives. The Company manages its business in three

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Principles of Consolidation and Basis of Presentation The accompanying unaudited consolidated financial statements include the accounts of Welbilt and its subsidiaries and have been prepared by the Company, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). The Company prepares its financial statements in accordance with accounting principles generally accepted in the U.S. ("U.S. GAAP"). All intercompany balances and transactions between the Company and its affiliates have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant items subject to such estimates and assumptions include inventory obsolescence costs, asset impairments, warranty costs, product liability costs, employee benefit programs, sales rebates, loss contingencies and the measurement of income tax assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On an ongoing basis, the Company evaluates these assumptions, judgments and estimates. Actual results may differ from these estimates. In the opinion of management, the consolidated financial statements contain all adjustments necessary for a fair statement of the results of operations and comprehensive loss for the three months ended March 31, 2020 and 2019 , the financial position as of March 31, 2020 and December 31, 2019 and the cash flows for the three months ended March 31, 2020 and 2019 , and except as otherwise discussed herein, such adjustments consist only of those of a normal recurring nature. The interim results are not necessarily indicative of results that may be achieved in a full reporting year. Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the SEC rules and regulations governing interim financial statements. However, the Company believes that the disclosures made in the unaudited consolidated financial statements and related notes are adequate to make the information presented not misleading. These consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2019 . All dollar amounts, except share and per share amounts, are in millions of dollars unless otherwise indicated. Recently Adopted Accounting Pronouncements In August 2018, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2018-15, "Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract," which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software, with amortization expense being recorded in the same income statement expense line as the hosted service costs and over the expected term of the hosting arrangement. This standard was effective for the Company on January 1, 2020 and has been adopted prospectively for applicable implementation costs incurred subsequent to the effective date. In June 2016, the FASB issued ASU 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," including subsequent amendments issued thereafter which clarify the standard (collectively, "Topic 326"), which significantly changes the impairment model for most financial instruments. Current guidance requires the recognition of credit losses based on an incurred loss impairment methodology that reflects losses once the losses are probable. In accordance with Topic 326, the Company will be required to use a current expected credit loss model (“CECL”) that will immediately recognize an estimate of credit losses that are expected to occur over the life of the financial instruments that are within the scope of this update, including trade receivables. The CECL model uses a broader range of reasonable and supportable information in the development of credit loss estimates. This standard was effective for the Company on January 1, 2020 and, upon adoption, the Company recorded an additional expected credit loss allowance with an offsetting adjustment to retained earnings of $0.4 million . In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting" ("ASU 2020-04") to provide temporary optional expedients and exceptions to U.S. GAAP guidance on contract modifications, hedge accounting and other transactions affected by the expected market transition from the London Interbank Offered Rate ("LIBOR") and other interbank offered rates to alternative reference rates. ASU 2020-04 is effective upon issuance and the Company may elect to apply the standard through December 31, 2022. This guidance primarily impacts the interest expense under the Company's 2016 Credit Facility which utilizes LIBOR as a basis. As the Company has not completed a modification of the interest component of this financial instrument and does not have related outstanding hedges in place as of March 31, 2020, the guidance has not impacted the Company's consolidated financial statements to date. The Company will evaluate the impact of adopting this guidance at the time such transition to an alternative reference rate occurs. Recently Issued Accounting Pronouncements Not Yet Adopted In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes" ("ASU 2019-12"), which amends, and is intended to simplify, existing guidance related to the accounting for income taxes. ASU 2019-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. This guidance is effective for the Company beginning January 1, 2021. The Company is currently evaluating the impact this new standard will have on the Company's consolidated financial statements. Recent accounting guidance not discussed is not applicable, did not have, or is not expected to have a material impact on the Company.

Accounts Receivable Securitizat

Accounts Receivable Securitization	3 Months Ended
	Mar. 31, 2020
Transfers and Servicing [Abstract]
Accounts Receivable Securitization	Accounts Receivable Securitization Prior to its termination on March 13, 2019, the Company participated in a $110.0 million accounts receivable securitization program whereby the Company sold certain of its domestic trade accounts receivable and certain of its non-U.S. trade accounts receivable to a wholly-owned, bankruptcy-remote, foreign special purpose entity, which would in turn, sell, convey, transfer and assign to a third-party financial institution (the “Purchaser”), all the rights, title and interest in and to its pool of receivables. Upon termination of the program, the Purchaser had no recourse for uncollectible receivables. During the period of this program, cash receipts from the Purchaser at the time of the sale were classified as operating activities while cash receipts from the beneficial interest on sold receivables were classified as investing activities on the Consolidated Statements of Cash Flows. In connection with the termination of the accounts receivable securitization program during the first quarter of 2019, $156.9 million of accounts receivable sold under the program were reacquired in exchange for the outstanding deferred purchase price receivable and cash, which was provided by receipts of previously sold trade receivables. Cash receipts on the reacquired receivables were $65.0 million for the three months ended March 31, 2019 and have been classified as an investing activity in the Company's Consolidated Statements of Cash Flows.

Inventories - Net

Inventories - Net	3 Months Ended
	Mar. 31, 2020
Inventory Disclosure [Abstract]
Inventories - Net	Inventories — Net The components of "Inventories — net" are as follows: (in millions) March 31, December 31, 2020 2019 Inventories — net: Raw materials $ 84.0 $ 81.4 Work-in-process 14.8 14.2 Finished goods 106.3 95.0 Total inventories at FIFO cost 205.1 190.6 Excess of FIFO costs over LIFO value (4.2 ) (4.2 ) Total inventories — net $ 200.9 $ 186.4

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets - Net	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets - Net	Goodwill and Other Intangible Assets — Net The Company's annual impairment tests of goodwill and intangible assets with indefinite lives are performed as of June 30 of each fiscal year and whenever a triggering event occurs between annual impairment tests. The Company's trademarks and tradenames are classified as indefinite-lived intangible assets as there are no regulatory, contractual, competitive, economic or other factors which limit the useful lives of these intangible assets. The goodwill impairment test is performed for the Company's reporting units, which are the Americas, EMEA and APAC. The long-lived asset impairment testing is performed at the Company's unit of account level, which is the Americas, EMEA and APAC. As a result of the decrease in demand for commercial foodservice equipment and aftermarket parts resulting from the COVID-19 pandemic and impacts on the Company's current and estimated future operating cash flows, management reviewed the Company's goodwill and indefinite-lived intangible assets to determine whether it was more-likely-than-not that the fair value of such assets was less than their carrying amount as of March 31, 2020. The review included the Company's evaluation of relevant events and circumstances in totality that affect the fair value of the reporting units or indefinite-lived intangible assets. These events and circumstances include, but are not limited to, macroeconomic conditions (including the impact of COVID-19), industry and competitive environment conditions, overall financial performance, business specific events and market considerations. The majority of the Company's goodwill and indefinite-lived intangible assets were generated on a legacy basis and as a result have fair values that sufficiently exceed their underlying carrying values. However, additional goodwill and indefinite-lived intangible assets attributable to the EMEA and APAC regions were generated as a result of a recent acquisition in April 2018. Management's review concluded for each of its reporting units and for the Americas indefinite-lived assets that it is not more-likely-than-not that the fair value is less than the carrying amount based on the preponderance of evidence. Therefore, no impairment is indicated and no impairment test was required to be performed as of March 31, 2020 . However, for both the EMEA and APAC indefinite-lived intangible assets, the review indicated, based on limited fair value cushion and overall financial performance expectations, that it is more-likely-than-not that the fair value of the indefinite-lived intangible assets is less than the carrying amount and, therefore, a quantitative impairment test was performed as of March 31, 2020 . The Company estimated the fair value of the EMEA and APAC indefinite-lived intangible assets based on an income approach using the relief-from-royalty method. This approach is dependent upon several factors, including estimates of future growth and trends, royalty rates, discount rates and other variables. Management based its fair value estimates on assumptions believed to be reasonable, but which are inherently uncertain and could materially affect the valuations. These estimated fair values were then compared to the carrying values of the relevant indefinite-lived intangible asset and to the extent the carrying value exceeded the estimated fair value, an impairment loss was recognized in the amount by which the carrying amount of the asset exceeded the estimated fair value of the asset. As of March 31, 2020 , the Company determined that the carrying value of the indefinite-lived intangible assets in the EMEA region exceeded their estimated fair value. As a result, an impairment charge was recognized in the amount of $11.1 million , which was recorded as a component of "Loss from impairment and disposal of assets — net" for the three months ended March 31, 2020 . Management determined that the fair value of the indefinite-lived intangible assets in the APAC region exceeded the carrying value of these assets and, therefore, concluded there was no impairment of these assets as of March 31, 2020. The duration and severity of the COVID-19 pandemic or other industry or competitive changes could result in additional future impairment charges to the Company's goodwill and remaining indefinite-lived intangible assets. Despite management's implemented strategies to address these events, a prolonged or more pronounced effect of the pandemic could negatively impact the results of operations and future financial performance expectations, resulting in changes in operating plans, or cause other adverse changes in the business, the foodservice industry or the macroeconomic environment, such as interest rate changes, that could trigger an impairment in the future. The changes in the carrying amount of goodwill by geographic business segment are as follows: (in millions) Americas EMEA APAC Total Gross balance as of December 31, 2019 $ 1,144.8 $ 284.1 $ 19.9 $ 1,448.8 Accumulated asset impairments (312.2 ) (203.5 ) — (515.7 ) Net balance as of December 31, 2019 $ 832.6 $ 80.6 $ 19.9 $ 933.1 Foreign currency impact $ — $ (2.8 ) $ (0.6 ) $ (3.4 ) Gross balance as of March 31, 2020 1,144.8 281.3 19.3 1,445.4 Accumulated asset impairments (312.2 ) (203.5 ) — (515.7 ) Net balance as of March 31, 2020 $ 832.6 $ 77.8 $ 19.3 $ 929.7 The gross carrying amounts, impairment charges and accumulated amortization of the Company's intangible assets, other than goodwill, are as follows: (in millions) March 31, 2020 December 31, 2019 Gross Impairment Charges Accumulated Net Gross Accumulated Net Customer relationships $ 470.7 $ — $ (249.8 ) $ 220.9 $ 472.8 $ (243.6 ) $ 229.2 Trademarks and trade names 214.8 (11.1 ) — 203.7 217.6 — 217.6 Other intangibles 165.7 — (112.2 ) 53.5 166.9 (109.8 ) 57.1 Patents 5.8 — (2.0 ) 3.8 5.8 (2.0 ) 3.8 Total $ 857.0 $ (11.1 ) $ (364.0 ) $ 481.9 $ 863.1 $ (355.4 ) $ 507.7

Property, Plant and Equipment -

Property, Plant and Equipment - Net	3 Months Ended
	Mar. 31, 2020
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment - Net	Property, Plant and Equipment — Net The components of "Property, plant and equipment — net" are as follows: (in millions) March 31, December 31, 2020 2019 Property, plant and equipment — net: Land $ 9.6 $ 9.7 Building and improvements 92.7 93.2 Machinery, equipment and tooling 220.9 223.3 Furniture and fixtures 7.4 7.6 Computer hardware and software for internal use 65.4 66.1 Construction in progress 21.5 22.0 Total cost 417.5 421.9 Less accumulated depreciation (292.9 ) (294.4 ) Total property, plant and equipment — net $ 124.6 $ 127.5

Accrued Expenses and Other Liab

Accrued Expenses and Other Liabilities	3 Months Ended
	Mar. 31, 2020
Payables and Accruals [Abstract]
Accrued Expenses and Other Liabilities	Accrued Expenses and Other Liabilities The components of "Accrued expenses and other liabilities" are as follows: (in millions) March 31, December 31, 2020 2019 Accrued expenses and other liabilities: Accrued rebates and commissions $ 32.6 $ 56.2 Miscellaneous accrued expenses 34.9 37.8 Employee related expenses 27.9 34.7 Interest payable 5.7 15.8 Operating lease liabilities 10.1 10.0 Restructuring liabilities 7.4 6.3 Business Transformation Program related expenses 4.1 5.8 Derivative liabilities 1.8 5.0 Income and other taxes payable 7.7 11.2 Deferred revenues 2.7 3.1 Customer deposits 2.9 3.1 Pension and postretirement health liabilities 2.1 2.1 Product liabilities 1.4 1.3 Total accrued expenses and other liabilities $ 141.3 $ 192.4

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was enacted on March 27, 2020 and includes many measures intended to assist companies during the COVID-19 pandemic including temporary changes to income and non-income-based tax laws, some of which were enacted under the Tax Cuts and Jobs Act ("Tax Act") in 2017. As a result of the Tax Act and the CARES Act, additional legislative and regulatory guidance has been and may continue to be issued, including final regulations that could impact our effective tax rate in future periods. For the three months ended March 31, 2020 , the Company recorded a $0.2 million income tax benefit, reflecting a 1.3% effective tax rate, compared to a $0.1 million income tax provision, reflecting a (4.0)% effective tax rate, recorded for the three months ended March 31, 2019 . The increase in effective tax rate for the three months ended March 31, 2020 compared to the same period of the prior year is primarily due to changes in discrete tax items as a result of the CARES Act and the relative weighting of jurisdictional income and loss. For the three months ended March 31, 2020 , the income tax benefit includes net discrete expenses of $4.6 million primarily related to the provisions of the CARES Act including changes allowing for net operating loss carryback and an increase in the allowable deduction limitation of interest expense (from 30% to 50% ), compared to $0.8 million discrete expenses related to stock-based compensation and foreign tax adjustments for the three months ended March 31, 2019 . The Company’s effective tax rate for the three months ended March 31, 2020 varies from the 21.0% U.S. federal statutory rate primarily due to discrete tax items generated from the provisions of the CARES Act for net operating loss carryback and interest limitations, foreign income or loss before income taxes, relative weighting of foreign earnings before income taxes, including the impact of the indefinite-lived intangible asset impairment in the Company's EMEA region. The Company's effective tax rate for the three months ended March 31, 2019 varies from the 21.0% U.S. federal statutory rate primarily due to the relative weighting of foreign earnings before income taxes, discrete tax items and taxes on foreign income. Foreign earnings are generated from operations in the Company’s three geographic segments, Americas, EMEA and APAC. As of each reporting date, the Company’s management considers new evidence, both positive and negative, that could impact management’s view regarding the future realization of deferred tax assets. The Company will continue to evaluate its valuation allowance requirements, including the U.S. interest expense limitation of the Tax Act, as temporarily modified under the CARES Act. Due to the revised interest deduction limitations of the CARES Act, the Company has determined that a valuation allowance is not required for the deferred tax asset associated with the U.S. interest expense as of March 31, 2020. The Company may adjust its deferred tax asset valuation allowances based on possible sources of taxable income that may be available to realize a tax benefit for deferred tax assets. As facts and circumstances change, the Company may adjust its deferred tax asset valuation allowances accordingly. Such changes in the deferred tax asset valuation allowances will be reflected in current operations through the Company’s income tax provision and could have a material effect on the Company’s operating results. The Company's unrecognized tax benefits, including interest and penalties, were $4.1 million and $4.2 million as of March 31, 2020 , and December 31, 2019 , respectively. During the next twelve months, it is reasonably possible that unrecognized tax benefits could change in the range of $0.1 million to $0.5 million due to the expiration of relevant statutes of limitations and federal, state and foreign tax audit resolutions. The Company regularly assesses the likelihood of an adverse outcome resulting from examinations to determine the adequacy of its tax reserves. The Company is currently under audit by the tax authorities in Germany for the years 2015-2018 and in the U.S. for the 2017 federal income tax return as well as various other state income tax and jurisdictional audits. As of March 31, 2020 , the Company believes that it is more-likely-than-not that the tax positions it has taken will be sustained upon the resolution of its audits resulting in no material impact on its consolidated financial position, results of operations and cash flows. However, the final determination with respect to any tax audits, and any related litigation, could be materially different from the Company's estimates and/or from its historical income tax provisions and accruals and could have a material effect on operating results and/or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties and/or interest assessments. As of March 31, 2020 , the Company intends to continue reinvesting foreign earnings indefinitely outside of the U.S. with certain limited exceptions, and has not recorded a deferred tax liability for U.S. state income taxes, foreign withholding or other foreign income taxes that would be due if cash is repatriated to the U.S. because those foreign earnings are considered permanently reinvested or may be remitted substantially free of any additional income or withholding taxes. While the Company does not anticipate a need to repatriate funds to the U.S. to satisfy domestic liquidity needs, management reviews cash positions regularly and, to the extent it is determined that all or a portion of foreign earnings will not remain indefinitely reinvested, the Company will record a liability for the additional taxes, if applicable, including foreign withholding taxes and U.S. state income taxes. Further, the determination of the amount of the unrecognized deferred tax liability related to the undistributed earnings is not practicable.

Debt

Debt	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Debt	Debt The carrying value of the Company's outstanding debt consists of the following: (in millions, except percentage data) March 31, 2020 December 31, 2019 Carrying Value Weighted Average Interest Rate Carrying Value Weighted Average Interest Rate Long-term debt and finance leases: Revolving Credit Facility $ 244.9 4.37 % $ 141.8 5.00 % Term Loan B Facility 855.0 4.50 % 855.0 5.11 % 9.50% Senior Notes due 2024 425.0 9.72 % 425.0 9.72 % Finance leases 2.2 4.83 % 2.5 4.83 % Total debt and finance leases, including current portion 1,527.1 1,424.3 Less current portion: Term Loan B Facility (0.8 ) — Finance leases (1.1 ) (1.2 ) Unamortized debt issuance costs (1) (19.5 ) (20.5 ) Hedge accounting fair value adjustment (2) 0.4 0.5 Total long-term debt and finance leases $ 1,506.1 $ 1,403.1 (1) Total debt issuance costs, net of amortization as of March 31, 2020 and December 31, 2019 were $21.9 million and $23.0 million, respectively, of which $2.4 million and $2.5 million, respectively, are related to the Revolving Credit Facility (as defined below) and recorded in "Other non-current assets" in the Consolidated Balance Sheets. (2) Balance represents deferred gains from the terminations of interest rate swaps designated as fair value hedges. In March 2016, the Company entered into a credit agreement, as amended, restated, supplemented or otherwise modified from time to time (the "2016 Credit Agreement") for a $1,300.0 million Senior Secured Credit Facility consisting of (i) a senior secured Term Loan B facility in an aggregate principal amount of $900.0 million (the "Term Loan B Facility") and (ii) a senior secured revolving credit facility in an aggregate principal amount of $400.0 million (the "Revolving Credit Facility"). The 2016 Credit Agreement also provides for (i) a sublimit for the issuance of letters of credit under the revolving commitments up to $30.0 million and (ii) an aggregate principal amount of allowed incremental revolving or term loan facilities thereunder in an amount not to exceed the sum of (a) $275.0 million plus (b) an additional amount, as long as after giving effect to the incurrence of such additional amount, the proforma secured leverage ratio does not exceed 3.75 : 1.00 . The maturities of the Term Loan B Facility and Revolving Credit Facility are October 2025 and October 2023, respectively. Through the first half of 2019, borrowings under the 2016 Credit Agreement bore interest at a rate per annum equal to, at the Company's option, either (i) LIBOR plus an applicable margin of 2.50% for the Term Loan B Facility and 1.50% to 2.50% for the Revolving Credit Facility (depending on the Company's Consolidated Total Leverage Ratio) or (ii) an alternate base rate plus an applicable margin that is 1.00% less than the LIBOR-based applicable margin. Beginning in the third quarter of 2019, the spreads for LIBOR and alternate base rate borrowings for the revolving credit facility were 2.25% and 1.25% , respectively. Due to the impact of the COVID-19 pandemic on the commercial foodservice industry and the resulting decrease in demand for the Company's products, on April 17, 2020, the Company further amended the 2016 Credit Agreement to amend the financial covenants of the Revolving Credit Facility to prevent non-compliance with financial covenants of the Revolving Credit Facility for the quarter ending June 30, 2020. In addition, the Company executed contingency plans for its operations and took steps to reduce operating expenses and capital spending as necessary, including reductions in the size of our workforce and temporary employee furloughs. The Company has estimated the negative impact of COVID-19 on its financial position, results of operations and cash flows, however, due to the inherent uncertainty of the COVID-19 pandemic on the Company's business, management's estimates of the achievement of its financial covenants may change in the future. See Note 20, "Subsequent Event," for additional information related to this amendment. As of March 31, 2020 , the Company had $4.1 million in outstanding stand-by letters of credit and $151.0 million available for additional borrowings under the Revolving Credit Facility, to the extent the Company's compliance with financial covenants permits such borrowings. As of March 31, 2020 , the Company also had $1.3 million in other outstanding letters of credit or guarantees of payment to certain third-parties in accordance with commercial terms and conditions which did not reduce the amount available for additional borrowing under the Revolving Credit Facility. The 2016 Credit Agreement contains financial covenants including, but not limited to (a) a Consolidated Interest Coverage Ratio, which measures the ratio of (i) Consolidated EBITDA to (ii) Consolidated Interest Expense, and (b) a Consolidated Total Leverage Ratio, which measures the ratio of (i) Consolidated Indebtedness to (ii) Consolidated EBITDA for the most recent four fiscal quarters, in each case, as defined in the 2016 Credit Agreement. In April 2018, the Company, through a wholly-owned subsidiary, entered into a short-term secured $30.0 million revolving loan facility for working capital requirements. This revolving loan facility bore interest at LIBOR plus an applicable margin of 1.90% and matured on April 18, 2019. The Company repaid the outstanding balance of the facility during the first quarter of 2019. As of March 31, 2020 , the Company was in compliance with all affirmative and negative covenants pertaining to its financing arrangements.

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company's risk management objective is to ensure that business exposures to risks that have been identified and measured and are capable of being controlled are minimized or managed using what the Company believes to be the most effective and efficient methods to eliminate, reduce or transfer such exposures. Operating decisions consider these associated risks and the Company structures transactions to minimize or manage these risks whenever possible. The primary risks the Company manages using derivative instruments are interest rate risk, commodity price risk and foreign currency exchange risk. The Company enters into interest rate swap agreements to manage interest rate risk associated with the Company’s fixed and floating-rate borrowings. Cross-currency interest rate swaps are entered into to protect the value of the Company’s investments in its foreign subsidiaries. Swap contracts on various commodities are used to manage the price risk associated with forecasted purchases of materials used in the Company's manufacturing process. The Company also enters into various foreign currency derivative instruments to manage foreign currency risk associated with its projected purchases and sales and foreign currency denominated receivable and payable balances. The Company recognizes all derivative instruments as either assets or liabilities at fair value in the Consolidated Balance Sheets. Commodity swaps and foreign currency exchange contracts are designated as cash flow hedges of forecasted purchases of commodities and currencies, certain interest rate swaps are designated as cash flow hedges of floating-rate borrowings, and the remainder of the instruments are designated as fair value hedges of fixed-rate borrowings and a cross-currency interest rate swap as a hedge of net investments in its foreign subsidiaries. Discontinuance of Cash Flow Hedge Accounting for Commodity Contracts Through September 30, 2019 the Company designated all of its commodity derivative contracts as cash flow hedges, for which unrealized changes in fair value were recorded to "Accumulated other comprehensive loss" ("AOCI") in the Company's Consolidated Balance Sheets , to the extent the commodity hedges were effective. As of October 1, 2019, the Company elected to de-designate all of its commodity derivative contracts and as a result, the Company now recognizes all future gains and losses from changes in the fair value of the commodity derivative immediately in earnings. As a result of discontinuing hedge accounting effective October 1, 2019, the associated amounts in AOCI as of September 30, 2019 remained in AOCI and will be reclassified into earnings when the original hedged transaction affects earnings or it becomes probable that the forecasted transactions will not occur. Cash flow hedging strategy For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative is recorded in AOCI in the Company's Consolidated Balance Sheets and is subsequently reclassified into earnings in the periods in which the hedged transaction affects earnings. During the next twelve months, the Company estimates $1.1 million of unrealized losses , net of tax, related to currency rate and commodity price hedging will be reclassified from AOCI into earnings. Foreign currency and commodity hedging, prior to de-designation, is generally completed prospectively on a rolling basis for 15 and 36 months , respectively, depending on the type of risk being hedged. In March 2017, the Company entered into two interest rate swap agreements with a total notional amount of $600.0 million , to manage interest rate risk exposure by converting the Company’s floating-rate debt to a fixed-rate basis, thus reducing the impact from fluctuations in interest rates on future interest expense. These interest rate swap agreements involved the receipt of floating rate amounts in exchange for fixed rate interest payments over the life of the agreements without an exchange of the underlying principal. These interest rate swap agreements with notional amounts of $425.0 million and $175.0 million matured in the first quarter of 2020 and 2019, respectively. The Company's outstanding currency forward contracts entered into as hedges of forecasted transactions are as follows: Currency Units Hedged March 31, December 31, 2020 2019 Canadian Dollar 4,608,000 8,014,000 Euro 4,073,000 7,593,000 British Pound 4,342,932 8,046,471 Mexican Peso 65,150,000 111,250,000 Singapore Dollar 1,210,000 2,019,000 The effects of the Company's derivative instruments on the Consolidated Statements of Comprehensive Income and Consolidated Statements of Operations for gains or losses initially recognized in AOCI in the Consolidated Balance Sheets were as follows: Derivatives in cash flow hedging relationships Pretax gain/(loss) recognized in AOCI Pretax gain/(loss) reclassified from AOCI into income (in millions) Three Months Ended March 31, Location Three Months Ended March 31, 2020 2019 2020 2019 Foreign currency exchange contracts $ (1.1 ) $ (0.1 ) Cost of sales $ (0.1 ) $ (0.3 ) Commodity contracts — 0.2 Cost of sales (0.5 ) (0.1 ) Interest rate swap contracts — (0.6 ) Interest expense — 1.1 Total $ (1.1 ) $ (0.5 ) $ (0.6 ) $ 0.7 Fair value hedging strategy For derivative instruments that qualify and are designated as a fair value hedge (i.e. hedging the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), the gain or loss on the derivative instrument as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in the same line item associated with the hedged item in the Company's Consolidated Statements of Operations. In October 2017, the Company entered into an interest rate swap agreement with a total notional amount of $425.0 million to manage interest rate risk exposure by converting the Company’s fixed-rate debt to a floating-rate basis. This agreement involved the receipt of fixed rate amounts in exchange for floating rate interest payments over the life of the agreement without an exchange of the underlying principal and had a scheduled maturity of February 2024. In June 2019, this interest rate swap agreement was terminated, and the Company received cash in the amount of $14.0 million , representing the fair value of the swap and interest accrued through the date of termination. Effect of Fair Value and Cash Flow Derivative Instruments on Consolidated Statements of Operations The table below presents the effect of the Company’s derivative financial instruments on the Consolidated Statements of Operations : (in millions) Location and amount of gain/(loss) recognized on effect of fair value and cash flow derivative instruments Three Months Ended Three Months Ended March 31, 2020 March 31, 2019 Cost of Sales Interest Expense Cost of Sales Interest Expense Total amounts of expense line items presented in the Consolidated Statements of Operations in which effects of fair value and cash flow hedges are recorded $ 214.1 $ 21.3 $ 248.8 $ 24.0 The effects of fair value and cash flow hedging: Gain/(loss) on fair value hedging relationship: Interest rate contract: Hedged item $ — $ 0.1 $ — $ (7.0 ) Derivative designated as hedging instrument $ — $ — $ — $ 6.6 Gain/(loss) on cash flow hedging relationships: Foreign currency exchange contracts: Amount of gain/(loss) reclassified from AOCI into income $ (0.1 ) $ — $ (0.3 ) $ — Commodity contracts: Amount of gain/(loss) reclassified from AOCI into income $ (0.5 ) $ — $ (0.1 ) $ — Interest rate contracts: Amount of gain/(loss) reclassified from AOCI into income $ — $ — $ — $ 1.1 Hedge of net investment in foreign operations strategy For derivative instruments that qualify and are designated as a hedge of a net investment in a foreign currency, the gain or loss is reported in AOCI as a component of the cumulative translation adjustment. Amounts are reclassified out of AOCI into earnings when the hedged net investment is either sold or substantially liquidated. In March 2017, the Company entered into a three -year cross-currency interest rate swap contract ("CCS") for a notional value of €50.0 million to protect the value of its net investment in Euros. Prior to its expiration in March 2020, the carrying value of the net investment in Euros was designated as a hedging instrument and remeasured at each reporting date to reflect the changes in the foreign currency exchange spot rate, with changes since the last remeasurement date recorded in AOCI. Upon expiration of the CCS in March 2020, the Company paid $4.1 million representing the final notional exchange at the expiration date spot exchange rate, which has been classified as an investing activity in the Company's Consolidated Statements of Cash Flows. The location and effects of the net investment hedge on the Consolidated Statements of Comprehensive Income and Consolidated Statements of Operations were as follows: Derivative in net investment hedging relationship Pretax gain/(loss) recognized in AOCI Gain/(loss) reclassified from AOCI into income Gain/(loss) recognized in income (amount excluded from effectiveness testing) (in millions) Three Months Ended Location Three Months Ended Location Three Months Ended March 31, March 31, March 31, 2020 2019 2020 2019 2020 2019 Interest rate swap contract $ (0.8 ) $ 1.6 N/A $ — $ — Other (income) expense — net $ 0.3 $ 0.4 N/A = Not applicable Derivatives Not Designated as Hedging Instruments The Company enters into commodity and foreign currency exchange contracts that are not designated as hedge relationships to offset, in part, the impact of certain intercompany transactions and to further mitigate certain other short-term commodity and currency impacts, as identified. For derivative instruments that are not designated as hedging instruments, the gains or losses on the derivatives are recognized in current earnings within " Other (income) expense — net " in the Consolidated Statements of Operations. The Company had the following outstanding commodity and currency forward contracts that were not designated as hedging instruments: Commodity Contracted Units Unit March 31, December 31, 2020 2019 Aluminum 392 524 MT Copper 189 269 MT Steel 908 1,778 Short tons Currency Contracted Units March 31, December 31, 2020 2019 Singapore Dollar 28,367,000 28,427,000 Euro 81,085,000 75,557,000 British Pound 26,488,585 20,323,932 Mexican Peso 13,500,000 11,805,000 Swiss Franc 6,400,000 7,000,000 Canadian Dollar 997,000 1,330,000 The location and impact on the Consolidated Statements of Operations for gains or losses related to derivative instruments not designated as hedging instruments are as follows: Derivatives NOT designated as hedging instruments Amount of gain/(loss) recognized in income on derivative Location of gain/(loss) recognized in income on derivative (in millions) Three Months Ended March 31, 2020 2019 Foreign currency exchange contracts $ (2.0 ) $ 2.8 Other (income) expense — net Commodity contracts (0.5 ) — Other (income) expense — net Total $ (2.5 ) $ 2.8 The fair value of outstanding derivative contracts recorded as assets in the Consolidated Balance Sheets are as follows: (in millions) Balance Sheet Location Asset Derivatives Fair Value March 31, December 31, 2020 2019 Derivatives designated as hedging instruments: Foreign currency exchange contracts Prepaids and other current assets $ — $ 0.8 Total derivatives designated as hedging instruments $ — $ 0.8 Derivatives NOT designated as hedging instruments: Foreign currency exchange contracts Prepaids and other current assets $ 0.6 $ 0.4 Total derivatives NOT designated as hedging instruments $ 0.6 $ 0.4 Total asset derivatives $ 0.6 $ 1.2 The fair value of outstanding derivative contracts recorded as liabilities in the Consolidated Balance Sheets are as follows: (in millions) Balance Sheet Location Liability Derivatives Fair Value March 31, December 31, 2020 2019 Derivatives designated as hedging instruments: Foreign currency exchange contracts Accrued expenses and other liabilities $ 0.8 $ 0.6 Interest rate swap contracts Accrued expenses and other liabilities — 3.2 Total derivatives designated as hedging instruments $ 0.8 $ 3.8 Derivatives NOT designated as hedging instruments: Foreign currency exchange contracts Accrued expenses and other liabilities $ 0.3 $ 0.6 Commodity contracts Accrued expenses and other liabilities 0.7 0.6 Total derivatives NOT designated as hedging instruments $ 1.0 $ 1.2 Total liability derivatives $ 1.8 $ 5.0

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments In accordance with the Company's policy, fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The policy classifies the inputs used to measure fair value into the following hierarchy: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities Level 2 Unadjusted quoted prices in active markets for similar assets or liabilities, or Unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or Inputs other than quoted prices that are observable for the asset or liability Level 3 Unobservable inputs for the asset or liability The Company utilizes the best available information in measuring fair value. The carrying values of cash and cash equivalents, accounts receivable and trade accounts payable approximate fair value, without being discounted, as of March 31, 2020 and December 31, 2019 , as applicable, due to the short-term nature of these instruments. The Company's Revolving Credit Facility, Term Loan B Facility and Senior Notes are recorded at their carrying values on the Company's Consolidated Balance Sheets , as disclosed in Note 9, "Debt." The carrying value of the Revolving Credit Facility approximates its fair value due to the short-term variable interest rates of the borrowings. The Company estimates the fair value of the Term Loan B Facility and the Senior Notes based on quoted market prices of the instruments. Because these instruments are typically thinly traded, the assets and liabilities are classified as Level 2 of the fair value hierarchy. The fair value of the Company's Term Loan B Facility was approximately $671.7 million and $860.9 million as of March 31, 2020 and December 31, 2019 , respectively. The fair value of the Company's Senior Notes was approximately $359.7 million and $450.9 million as of March 31, 2020 and December 31, 2019 , respectively. The following tables set forth financial assets and liabilities that were accounted for at fair value on a recurring basis by level within the fair value hierarchy. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement: (in millions) Fair Value March 31, 2020 Level 1 Level 2 Level 3 Total Current assets: Foreign currency exchange contracts $ — $ 0.6 $ — $ 0.6 Total current assets at fair value — 0.6 — 0.6 Total assets at fair value $ — $ 0.6 $ — $ 0.6 Current liabilities: Foreign currency exchange contracts $ — $ 1.1 $ — $ 1.1 Commodity contracts — 0.7 — 0.7 Total current liabilities at fair value — 1.8 — 1.8 Total liabilities at fair value $ — $ 1.8 $ — $ 1.8 (in millions) Fair Value December 31, 2019 Level 1 Level 2 Level 3 Total Current assets: Foreign currency exchange contracts $ — $ 1.2 $ — $ 1.2 Total current assets at fair value — 1.2 — 1.2 Total assets at fair value $ — $ 1.2 $ — $ 1.2 Current liabilities: Foreign currency exchange contracts $ — $ 1.2 $ — $ 1.2 Commodity contracts — 0.6 — 0.6 Interest rate swap contracts — 3.2 — 3.2 Total current liabilities at fair value — 5.0 — 5.0 Total liabilities at fair value $ — $ 5.0 $ — $ 5.0

Contingencies and Significant E

Contingencies and Significant Estimates	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Contingencies and Significant Estimates	Contingencies and Significant Estimates Product-Related and Environmental Matters As of March 31, 2020 and December 31, 2019 , the Company had reserved $42.0 million and $43.9 million , respectively, for warranty claims expected to be paid. Certain of these warranty and other related claims involve matters in dispute that will ultimately be resolved by negotiations, arbitration or litigation. See Note 13, "Product Warranties," for further information. As of March 31, 2020 , the Company has various product liability lawsuits pending. For products sold outside of the U.S. and Canada, the Company is insured by third-party insurance companies. For products sold in the U.S. and Canada, the Company is insured, to the extent permitted under applicable law, with self-insurance retention levels. The Company's self-insurance retention levels vary by business and fluctuate with the Company's risk management practices. In the U.S., the Company's current self-insured retention level is $0.3 million per occurrence and $1.0 million in the aggregate for product liability claims. In Canada, the Company's current self-insured retention level is $0.1 million per occurrence and $2.0 million in the aggregate for product liability claims. In addition, the Company's current self-insured retention level for commercial general liability is $2.0 million in the aggregate. Product liability reserves are included in "Accrued expenses and other liabilities" in the Consolidated Balance Sheets and totaled $1.4 million and $1.3 million as of March 31, 2020 and December 31, 2019 , respectively, of which $0.8 million and $0.7 million , respectively, was reserved for specific cases and of which $0.6 million was reserved for each period for claims, calculated using actuarial methods, anticipated to have occurred but are not yet reported. Based on the Company's experience in defending product liability claims, management believes the reserves are adequate for estimated case resolutions on aggregate self-insured claims and third-party insured claims. Any recoveries from insurance carriers are dependent upon the legal sufficiency of claims and solvency of insurance carriers. As of both March 31, 2020 and December 31, 2019 , the Company held reserves for environmental matters related to certain of its current and former facilities of approximately $0.7 million , which are included in "Accrued expenses and other liabilities" in the Company's Consolidated Balance Sheets. At certain of the Company's other facilities, potential contaminants in the soil and groundwater have been identified. The ultimate cost of any required remediation will depend upon the results of future investigation and is not reasonably estimable. Based upon available information, the Company does not expect the ultimate costs of any required remediation at any of these facilities will have a material adverse effect on its financial condition, results of operations or cash flows individually or in the aggregate. It is reasonably possible that the estimates for product warranty, product liability and environmental remediation costs may change based upon new information that may arise or matters that are beyond the scope of the Company's historical experience. Presently, there are no reliable methods to estimate the amount of any such potential changes. Other Contingencies The Company is subject to litigation, government inquiries, audits, commercial disputes, claims and other legal proceedings arising in the ordinary course of business. From time to time, the Company may be subject to audits by tax, export, customs and other governmental authorities or incur routine and non-routine fees, expenses or penalties relating to compliance with complex laws and regulations impacting the Company's business. The Company records accruals for anticipated losses related to legal and other matters, which are both probable and reasonably estimable, as well as for related legal costs as incurred. The Company believes that it has adequately accrued for such matters as of March 31, 2020 based on the best available information. In the opinion of management, the ultimate resolution of such legal and other matters is not expected to have, individually or in the aggregate, a material adverse effect on the Company's financial condition, results of operations or cash flows. On December 13, 2018, a purported securities class action lawsuit was filed in the U.S. District Court for the Middle District of Florida against the Company and certain of its former executive officers. The lawsuit was captioned Schlimm v. Welbilt, Inc., et al.,("Schlimm lawsuit") and alleged that the defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b-5 promulgated thereunder, by making material misstatements or omissions in certain of its periodic reports filed with the SEC relating to, among other things, the Company's business operations and the effectiveness of its internal control over financial reporting. The lawsuit sought an unspecified amount of damages and an award of attorney’s fees, in addition to other relief. On October 17, 2019, the defendants filed a motion to dismiss the lawsuit. On February 6, 2020, the Court issued an order granting defendants’ motion and dismissed the Schlimm lawsuit without prejudice. On March 30, 2020, the Court issued an amended order of dismissal with prejudice. On April 2, 2020, the plaintiffs filed a notice of appeal regarding the Court’s order granting the defendants’ motion to dismiss. The appeal is pending. On March 15, 2019, a purported stockholder derivative action was filed in the U.S. District Court for the District of Delaware against certain of the Company's current and former executive officers and directors, and the Company was named as a nominal defendant. The lawsuit is captioned Quinney v. Muehlhaeuser, et al., ("Quinney lawsuit" ) and alleges violation of Section 14(a) of the Securities Exchange Act of 1934 and breach of fiduciary duty, among other claims, based upon similar underlying allegations as those in the Schlimm lawsuit. The Quinney lawsuit seeks an unspecified amount of damages and an award of attorney’s fees, in addition to other relief. On June 5, 2019, the Delaware court stayed the Quinney lawsuit, pending further developments in the Schlimm lawsuit. On April 1, 2020, the parties filed a stipulation of dismissal, and the Delaware court dismissed the Quinney lawsuit without prejudice. On September 4, 2019, a purported stockholder derivative action was filed in the U.S. District Court for the Middle District of Florida against certain of the Company's current and former executive officers and directors, and the Company was named as a nominal defendant. The lawsuit was captioned The Lee S. Kosby Trust v. Muehlhaeuser, et al., ("Kosby lawsuit") and alleged violation of Section 14(a) of the Securities Exchange Act of 1934 and breach of fiduciary duty, among other claims, based upon similar underlying allegations as those in the Quinney and Schlimm lawsuits. The Kosby lawsuit sought an unspecified amount of damages and an award of attorney’s fees, in addition to other relief. On March 18, 2020, the plaintiff filed a notice of voluntary dismissal, and on March 19, 2020, the Florida court dismissed the Kosby lawsuit without prejudice. The Company intends to defend vigorously against all lawsuits, as they may arise in the ordinary course of business. However, litigation is inherently uncertain, and the Company is unable to predict the outcome of these lawsuits and is unable to estimate the range of loss, if any, that could result from an unfavorable outcome. The Company also cannot provide any assurance that the ultimate resolution of each of these lawsuits will not have a material adverse effect on the Company's future results of operations or financial condition. The Company voluntarily disclosed to U.S. Customs and Border Protection ("CBP") certain errors in the declaration of imported products relating to quantity, value, classification, North American Free Trade Agreement eligibility and other matters as well as potential violations of antidumping and countervailing duties. Following such disclosures, the Company began a comprehensive review of its import practices in order to quantify the loss of revenue to CBP. In April 2020, the Company determined based on its analysis of relevant records of import activity an estimated range of potential loss for customs duties, fees and interest owed for previously imported products through March 31, 2020 to be $3.1 million to $9.0 million . Additional losses will continue to be generated for future period activity and interest until the disclosure is perfected with CBP. No amount within the range of loss is more likely than any other and, therefore, the Company recorded a charge of $3.1 million representing the low end of the range of potential loss. This charge has been included as a component of "Restructuring and other expenses" in the Consolidated Statements of Operations for the three months ended March 31, 2020 and "Accrued expenses and other liabilities" in the Consolidated Balance Sheets as of March 31, 2020 . The Company's analysis is ongoing and it expects to settle the final determination of the obligation in cash at such time that its disclosure is perfected with CBP. The Company cannot predict with any certainty the outcome of CBP's review of the Company's analysis.

Product Warranties

Product Warranties	3 Months Ended
	Mar. 31, 2020
Guarantees and Product Warranties [Abstract]
Product Warranties	Product Warranties In the normal course of business, the Company provides its customers with product warranties covering workmanship, and in some cases materials, on products manufactured by the Company. Such product warranties generally provide that products will be free from defects for periods ranging from 12 to 60 months , with certain equipment having longer-term warranties. If a product fails to comply with the Company's warranty, the Company may be obligated, at its expense, to correct any defect by repairing or replacing such defective products. The Company accrues an estimate of costs that may be incurred under the product warranty at the time the product revenue is recognized. These costs include estimates of labor and materials, as necessary, associated with repair or replacement of the products. The primary factors which affect the warranty liability include the number of units shipped and historical and anticipated warranty claims. As these factors are impacted by actual experience and future expectations, the Company assesses the adequacy of its recorded warranty liability on an ongoing basis and adjusts the liability as determined necessary. The product warranty liability activity for the three months ended March 31, 2020 is as follows: (in millions) Balance as of December 31, 2019 (1) $ 43.9 Additions for issuance of warranties 8.4 Settlements (in cash or in kind) (9.5 ) Currency translation impact (0.8 ) Balance as of March 31, 2020 (1) $ 42.0 (1) Long-term product warranty liabilities are included in "Other long-term liabilities" and totaled $10.1 million and $10.6 million as of March 31, 2020 and December 31, 2019, respectively. The Company also sells extended warranties, which are recorded as deferred revenue and are amortized to "Net sales" on a straight-line basis over the warranty period. The short-term portion of deferred revenue on extended warranties, included in "Accrued expenses and other liabilities" in the Consolidated Balance Sheets as of both March 31, 2020 and December 31, 2019 , was $1.8 million . The long-term portion of deferred revenue on extended warranties, included in "Other long-term liabilities" in the Consolidated Balance Sheets as of March 31, 2020 and December 31, 2019 , was $3.7 million and $3.8 million

Employee Benefit Plans

Employee Benefit Plans	3 Months Ended
	Mar. 31, 2020
Retirement Benefits [Abstract]
Employee Benefit Plans	Employee Benefit Plans The Company sponsors and maintains defined benefit retirement plans and postretirement health and other plans for certain retired and resigned employees. Benefits under the employee retirement plans are primarily based on years of service and compensation during the years immediately preceding retirement. The current plans are based largely upon benefit plans maintained prior to the spin-off from the Company's former parent and are generally closed to new participants. The components of the periodic benefit costs for the defined benefit plans are as follows: (in millions) Three Months Ended March 31, 2020 2019 Pension Plans Postretirement Pension Plans Postretirement Interest cost of projected benefit obligations $ 1.0 $ — $ 1.3 $ 0.1 Expected return on assets (1.0 ) — (1.2 ) — Amortization of prior service cost — (0.1 ) — — Amortization of actuarial net loss 0.6 0.2 0.5 0.1 Settlement loss recognized — — 1.2 — Net periodic benefit cost $ 0.6 $ 0.1 $ 1.8 $ 0.2 The components of periodic benefit costs are included in "Other (income) expense — net" in the Consolidated Statements of Operations. During the first quarter of 2019, the Company took various actions to settle a portion of its United Kingdom pension obligations. These actions resulted in a reduction in accrued pension obligations of approximately $5.5 million and a non-cash settlement loss of approximately $1.2 million , related to the accelerated recognition of unamortized losses for the three months ended March 31, 2019, which are included in "Other (income) expense — net" in the Consolidated Statements of Operations

Business Transformation Program

Business Transformation Program and Restructuring	3 Months Ended
	Mar. 31, 2020
Restructuring and Related Activities [Abstract]
Business Transformation Program and Restructuring	Business Transformation Program and Restructuring Business Transformation Program During the first quarter of 2019, the Company initiated a comprehensive operational review to validate the Company's long-term growth and margin targets and to refine the Company's execution plans, which culminated in launching the Business Transformation Program ("Transformation Program") in May 2019. The Transformation Program is structured in multiple phases and is focused on specific areas of opportunity including strategic sourcing, manufacturing facility workflow redesign, distribution and administrative process efficiencies and optimizing the Company's global brand platforms. The Company currently expects the Transformation Program to extend through 2021, however, the business disruption resulting from the global COVID-19 pandemic and the uncertainty around the timing and extent of its impacts may extend the execution costs and related savings the Company expects from this program. For the three months ended March 31, 2020 and 2019 , the Transformation Program costs consisted primarily of fees for consulting services. The components of Transformation Program expense incurred are as follows: (in millions) Three Months Ended March 31, 2020 2019 Transformation Program expense: Cost of sales $ 0.8 $ — Selling, general and administrative expenses 10.8 5.8 Total $ 11.6 $ 5.8 Restructuring The Company periodically takes action to improve operating efficiencies, typically in connection with recognizing cost synergies and rationalizing the cost structure of the Company, including actions associated with the Transformation Program. These actions generally include facility rationalization, headcount reductions and organizational integration activities resulting from discrete restructuring events, which are supported by approved plans for workforce reductions. The Company's restructuring activity and balance of the restructuring liability is as follows: (in millions) 2020 Plans 2019 and Previous Plans Total Workforce reductions Workforce reductions Other Pension withdrawal obligation Restructuring liability as of December 31, 2019 $ — $ 5.0 $ — $ 9.9 $ 14.9 Restructuring activities 2.8 0.8 0.1 — 3.7 Cash payments (0.4 ) (2.0 ) — (0.3 ) (2.7 ) Non-cash adjustments (1) (0.1 ) — (0.1 ) — (0.2 ) Restructuring liability as of March 31, 2020 $ 2.3 $ 3.8 $ — $ 9.6 $ 15.7 ( 1) Non-cash adjustments represent stock-based compensation resulting from the accelerated vesting of certain stock awards and accelerated depreciation recorded during the period. As of March 31, 2020 and December 31, 2019 , the current portion of the restructuring liability was $7.4 million and $6.3 million , respectively, and was included in "Accrued expenses and other liabilities" in the Consolidated Balance Sheets. As of March 31, 2020 and December 31, 2019 , the long-term portion of the restructuring liability was $8.3 million and $8.6 million , respectively, and was included in "Other long-term liabilities" in the Consolidated Balance Sheets. The long-term portion of the restructuring liability consists of the pension withdrawal obligation incurred in connection with the reorganization and plant restructuring of one of the Company's former operating entities and is expected to be satisfied in April of 2026. The Company's restructuring expense by segment is as follows: (in millions) Three Months Ended March 31, 2020 2019 Americas $ 2.2 $ 1.7 EMEA 0.3 0.4 APAC 0.5 0.1 Corporate 0.7 2.0 Total restructuring activities $ 3.7 $ 4.2 The Company's restructuring expense is reported as follows in the Consolidated Statements of Operations : (in millions) Three Months Ended March 31, 2020 2019 Cost of sales $ 0.1 $ — Restructuring and other expenses 3.6 4.2 Total restructuring activities $ 3.7 $ 4.2 During the first quarter of 2020, the Company executed a workforce reduction in the Americas region and Corporate as well as a limited management restructuring to reduce operating expenses primarily in response to the negative impact of the global COVID-19 pandemic on the Company's operations. As a result of these actions, the Company expects to incur severance and related costs of approximately $4.0 million , consisting of $2.2 million in the Americas region and $1.8 million in the Corporate division. During the first quarter of 2020, the Company recognized $2.8 million of these severance and related costs, consisting of $2.2 million in the Americas and $0.6 million in the Corporate division, which are included in "Restructuring and other expenses" in the Consolidated Statements of Operations. The remaining $1.2 million of restructuring costs are expected to be recognized through the second quarter of 2020. During the first quarter of 2020, the Company also recognized $0.8 million of severance and related costs included in "Restructuring and other expenses" and $0.1 million of accelerated depreciation included in "Cost of sales" in connection with restructuring actions initiated during the fourth quarter of 2019 in the EMEA and APAC regions. The remaining $1.3 million of restructuring costs related to these actions are expected to be recognized throughout the remainder of the year ending December 31, 2020 as the details of the restructuring actions are communicated to the remaining impacted employees and continuing service requirements are met. As the Company completes payments on each of its approved plans, the remaining restructuring liability is adjusted for the actual amounts incurred. No material adjustments for prior period restructuring liabilities were incurred in the three months ended March 31, 2020 and 2019, respectively. During the first quarter of 2019, the Company recognized $4.2 million of severance and related costs resulting from a global workforce reduction and limited executive management and restructuring actions during the first quarter of 2019. The remaining $1.2 million of severance and related costs was recognized during the second quarter of 2019 related to continuing service requirements associated with these actions. These severance and related costs are included in "Restructuring and other expenses" in the Company's Consolidated Statements of Operations during the respective periods incurred.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss Comprehensive income includes foreign currency translation adjustments, changes in the fair value of certain financial derivative instruments that quality for hedge accounting and actuarial gains and losses arising from the Company's employee pension and postretirement benefit obligations. The components of the Company's AOCI are as follows: (in millions) March 31, December 31, 2020 2019 Accumulated other comprehensive loss: Foreign currency translation, net of income tax benefit of $0.9 million and $1.6 million, respectively $ (32.5 ) $ (4.3 ) Derivative instrument fair market value, net of income tax expense of $0.7 million and $0.8 million, respectively (2.0 ) (1.6 ) Employee pension and postretirement benefit adjustments, net of income tax benefit of $6.4 million and $6.5 million, respectively (33.6 ) (35.6 ) Total accumulated other comprehensive loss $ (68.1 ) $ (41.5 ) The summary of changes in AOCI for the three months ended March 31, 2020 and 2019 are as follows: (in millions) Foreign Currency Translation (1) Gains and Losses on Cash Flow Hedges Pension & Postretirement Total Balance as of December 31, 2019 $ (4.3 ) $ (1.6 ) $ (35.6 ) $ (41.5 ) Other comprehensive (loss) income before reclassifications (27.5 ) (1.1 ) 1.4 (27.2 ) Reclassifications — 0.6 0.7 1.3 Tax effect (0.7 ) 0.1 (0.1 ) (0.7 ) Net current period other comprehensive (loss) income (28.2 ) (0.4 ) 2.0 (26.6 ) Balance as of March 31, 2020 $ (32.5 ) $ (2.0 ) $ (33.6 ) $ (68.1 ) (in millions) Foreign Currency Translation (1) Gains and Losses on Cash Flow Hedges Pension & Postretirement Total Balance as of December 31, 2018 $ (6.5 ) $ 0.8 $ (35.9 ) $ (41.6 ) Other comprehensive income (loss) before reclassifications 0.3 (0.5 ) (2.9 ) (3.1 ) Reclassifications — (0.7 ) 1.8 1.1 Tax effect (0.3 ) 0.2 (0.1 ) (0.2 ) Net current period other comprehensive loss — (1.0 ) (1.2 ) (2.2 ) Balance as of March 31, 2019 $ (6.5 ) $ (0.2 ) $ (37.1 ) $ (43.8 ) (1) Income taxes are not provided for foreign currency translation relating to indefinite investments in foreign subsidiaries, although the income tax effects within cumulative translation does include the impact of the net investment hedge transaction through its expiration in March 2020. Reclassification adjustments are made to avoid including items in both comprehensive income and net earnings. Reclassifications from AOCI, net of tax, to income were as follows: (in millions) Three Months Ended March 31, Recognized Location 2020 2019 (Losses) gains on cash flow hedges: Foreign currency exchange contracts $ (0.1 ) $ (0.3 ) Cost of sales Commodity contracts (0.5 ) (0.1 ) Cost of sales Interest expense — 1.1 Interest expense (Losses) gains on cash flow hedges, before tax (0.6 ) 0.7 Tax effect 0.1 0.1 Income taxes (Losses) gains on cash flow hedges, net of tax $ (0.5 ) $ 0.8 Amortization of pension and postretirement items: Amortization of prior service cost $ 0.1 $ — Other (income) expense — net Actuarial losses (0.8 ) (0.6 ) Other (income) expense — net Pension settlement — (1.2 ) Other (income) expense — net Amortization of pension and postretirement items, before tax (0.7 ) (1.8 ) Tax effect 0.1 0.1 Income taxes Amortization of pension and postretirement items, net of tax $ (0.6 ) $ (1.7 ) Total reclassifications, net of tax $ (1.1 ) $ (0.9 )

Loss Per Share

Loss Per Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Loss Per Share	Loss Per Share The Company presents loss per share on a basic and diluted basis. Basic loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the reported period. Since the Company reported a net loss for each of the periods presented, basic loss per share is the same as diluted loss per share as the inclusion of all potential shares of common stock would be antidilutive. The following table summarizes the number of shares of common stock issuable pursuant to the Company's outstanding stock-based compensation awards that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average market price of the common shares: March 31, March 31, 2020 2019 Potential shares of common stock: Stock options 2,372,495 2,232,634 Unvested restricted stock units 575,758 438,978 Unvested performance share units (1) 691,494 617,068 Total potential shares of common stock 3,639,747 3,288,680 (1) The number of performance share units that vest is determined for each grant based on the achievement of certain Company performance criteria over the 3 -year period, as set forth in each respective award agreement, and may range from zero to 200% of the target shares granted. The unvested performance share units are presented at 100%

Business Segments

Business Segments	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Business Segments	Business Segments The Company identifies its geographic business segments using the "management approach," which designates the internal organization used by management for making operating decisions and assessing performance as the source for determining the Company's geographic business segments. Management organizes and manages the business based on three geographic business segments: the Americas, EMEA and APAC. The accounting policies of the Company's geographic business segments are the same as those described in Note 2, "Basis of Presentation and Summary of Significant Accounting Policies." The Company evaluates segment performance based on an "Adjusted Operating EBITDA" result. Adjusted Operating EBITDA is defined as net earnings before interest expense, income taxes, other income or expense, depreciation and amortization expense plus certain other items such as loss from impairment of assets, gain or loss from disposal of assets, restructuring activities, loss on modification or extinguishment of debt, acquisition-related transaction and integration costs, Transformation Program expense and certain other items . In addition, certain corporate-level expenses and eliminations are not allocated to the segments. These unallocated expenses include corporate overhead, stock-based compensation expense and certain other non-operating expenses. The Company's presentation of Adjusted Operating EBITDA may not be comparable to similar measures used by other companies. During the first quarter of 2020, the Company revised the allocation of certain of its functional expenses between the corporate-level and the geographic business segments. Management believes the revised allocation methodology better aligns the operating results of the geographic business segments with how management assesses performance and makes operating decisions. The prior period segment results and related disclosures have been recast to conform to the current period presentation. These changes did not impact the Company's previously reported consolidated financial results. Financial information relating to the Company's geographic business segments is as follows: (in millions, except percentage data) Three Months Ended March 31, 2020 2019 Net sales: Americas $ 250.5 $ 275.1 EMEA 90.0 106.7 APAC 51.3 54.8 Elimination of intersegment sales (62.9 ) (61.3 ) Total net sales $ 328.9 $ 375.3 Segment Adjusted Operating EBITDA: Americas $ 52.3 $ 44.5 EMEA 13.6 18.2 APAC 8.2 7.9 Total Segment Adjusted Operating EBITDA 74.1 70.6 Corporate and unallocated expenses (28.6 ) (20.5 ) Amortization expense (10.0 ) (9.5 ) Depreciation expense (5.2 ) (4.9 ) Transaction costs (1) (0.1 ) (0.4 ) Other items (2) (3.1 ) (0.8 ) Transformation Program expense (3) (11.6 ) (5.8 ) Restructuring activities (4) (3.7 ) (4.2 ) Loss from impairment and disposal of assets — net (11.2 ) — Earnings from operations 0.6 24.5 Interest expense (21.3 ) (24.0 ) Other income (expense) — net 5.4 (3.0 ) Loss before income taxes $ (15.3 ) $ (2.5 ) (1) Transaction costs are associated with acquisition-related transaction and integration activities. Transaction costs recorded in "Cost of Sales" include $0.2 million related to inventory fair value purchase accounting adjustments for the three months ended March 31, 2019. Professional services and other direct acquisition and integration costs recorded in "Selling, general and administrative expenses" were $0.1 million and $0.2 million for the three months ended March 31, 2020 and 2019, respectively. (2) Other items are costs which are not representative of the Company's operational performance. For the three months ended March 31, 2020, other items represent the loss contingency estimate of amounts due for custom duties, fees and interest on previously imported products, which are included in "Restructuring and other expenses." Refer to Note 12, "Contingencies and Significant Estimates" for discussion of the impact to the Consolidated Statements of Operations. For the three months ended March 31, 2019, the amount represents other professional fees which are included in "Selling, general and administrative expenses." (3) Transformation Program expense includes consulting and other costs associated with executing the Company's Transformation Program initiatives. Refer to Note 15, "Business Transformation Program and Restructuring" for discussion of the impact to the Consolidated Statements of Operations. (4) Restructuring activities includes costs associated with actions to improve operating efficiencies and rationalization of the Company's cost structure. Refer to Note 15, "Business Transformation Program and Restructuring" for discussion of the impact to the Consolidated Statements of Operations. Adjusted Operating EBITDA % by segment (5) : Americas 20.9 % 16.2 % EMEA 15.1 % 17.1 % APAC 16.0 % 14.4 % (5) Adjusted Operating EBITDA % is calculated by dividing Adjusted Operating EBITDA by net sales for each respective segment. (in millions) Three Months Ended March 31, 2020 2019 Third-party net sales by geographic area (6) : United States $ 204.4 $ 225.0 Other Americas 18.5 20.3 EMEA 69.2 88.6 APAC 36.8 41.4 Total net sales by geographic area $ 328.9 $ 375.3 (6) Net sales in the section above are attributed to geographic regions based on location of customer. Net sales by product class and geographic business segment are as follows: (in millions) Three Months Ended March 31, 2020 Commercial Foodservice Equipment Aftermarket Parts and Support Total Americas $ 182.0 $ 36.1 $ 218.1 EMEA 56.0 15.6 71.6 APAC 32.0 7.2 39.2 Total net sales $ 270.0 $ 58.9 $ 328.9 (in millions) Three months ended March 31, 2019 Commercial Foodservice Equipment Aftermarket Parts and Support Total Americas $ 202.6 $ 38.2 $ 240.8 EMEA 77.5 13.4 90.9 APAC 36.0 7.6 43.6 Total net sales $ 316.1 $ 59.2 $ 375.3 Total assets by geographic segment are as follows: (in millions) March 31, December 31, 2020 2019 Americas $ 1,529.1 $ 1,528.0 EMEA 336.0 349.8 APAC 202.3 211.8 Corporate 117.6 75.7 Total assets $ 2,185.0 $ 2,165.3

Subsidiary Guarantors and Senio

Subsidiary Guarantors and Senior Notes	3 Months Ended
	Mar. 31, 2020
Condensed Financial Information Disclosure [Abstract]
Subsidiary Guarantors and Senior Notes	Subsidiary Guarantors and Senior Notes The following tables present consolidating financial information for (a) Welbilt ("Parent"); (b) the guarantors of the Senior Notes, which include substantially all of the domestic, 100% owned subsidiaries of Welbilt ("Guarantor Subsidiaries"); and (c) the wholly-owned foreign subsidiaries of Welbilt, which do not guarantee the Senior Notes ("Non-Guarantor Subsidiaries"). The information includes elimination entries necessary to consolidate the Guarantor Subsidiaries and the Non-Guarantor Subsidiaries. Investments in subsidiaries are accounted for using the equity method of accounting. The principal elimination entries eliminate investments in subsidiaries, equity and intercompany balances and transactions. Separate financial statements of the Guarantor Subsidiaries are not presented because as guarantors, these subsidiaries are fully and unconditionally, jointly and severally liable under the guarantees, except for normal and customary release provisions. As disclosed in Note 18, "Business Segments," the Company revised the allocation of certain of its functional expenses between the corporate-level and the geographic business segments during the first quarter of 2020. The impacts of the revised allocation predominantly impact the Parent and Guarantor Subsidiaries financial information reflected in the tables below. The prior period has been recast to conform to the current period presentation. These changes did not impact the Company's previously reported consolidated financial results. WELBILT, INC. Consolidating Statement of Operations (Unaudited) (in millions) Three Months Ended March 31, 2020 Parent Guarantor Non- Consolidating Adjustments Consolidated Net sales $ — $ 233.1 $ 210.9 $ (115.1 ) $ 328.9 Cost of sales — 170.0 159.2 (115.1 ) 214.1 Gross profit — 63.1 51.7 — 114.8 Selling, general and administrative expenses 18.1 32.8 35.6 — 86.5 Amortization expense — 7.1 2.6 — 9.7 Restructuring and other expenses 0.7 4.8 1.3 — 6.8 Loss from impairment and disposal of assets — net — — 11.2 — 11.2 (Loss) earnings from operations (18.8 ) 18.4 1.0 — 0.6 Interest expense 20.8 0.2 0.3 — 21.3 Other (income) expense — net (4.1 ) (6.3 ) 5.0 — (5.4 ) Equity in earnings (loss) of subsidiaries 5.0 (4.4 ) — (0.6 ) — (Loss) earnings before income taxes (30.5 ) 20.1 (4.3 ) (0.6 ) (15.3 ) Income taxes (15.4 ) 15.1 0.1 — (0.2 ) Net (loss) earnings $ (15.1 ) $ 5.0 $ (4.4 ) $ (0.6 ) $ (15.1 ) Total other comprehensive loss, net of tax (26.6 ) (25.0 ) (24.6 ) 49.6 (26.6 ) Comprehensive loss $ (41.7 ) $ (20.0 ) $ (29.0 ) $ 49.0 $ (41.7 ) WELBILT, INC. Consolidating Statement of Operations (Unaudited) (in millions) Three months ended March 31, 2019 Parent Guarantor Non- Consolidating Adjustments Consolidated Net sales $ — $ 247.2 $ 231.0 $ (102.9 ) $ 375.3 Cost of sales 1.0 188.6 162.1 (102.9 ) 248.8 Gross profit (1.0 ) 58.6 68.9 — 126.5 Selling, general and administrative expenses 20.6 35.3 32.4 — 88.3 Amortization expense — 7.1 2.4 — 9.5 Restructuring and other expenses 1.5 1.3 1.4 — 4.2 (Loss) earnings from operations (23.1 ) 14.9 32.7 — 24.5 Interest expense 21.8 0.2 2.0 — 24.0 Other (income) expense — net (6.4 ) (0.7 ) 10.1 — 3.0 Equity in earnings of subsidiaries 27.1 14.8 — (41.9 ) — (Loss) earnings before income taxes (11.4 ) 30.2 20.6 (41.9 ) (2.5 ) Income taxes (8.8 ) 3.1 5.8 — 0.1 Net (loss) earnings $ (2.6 ) $ 27.1 $ 14.8 $ (41.9 ) $ (2.6 ) Total other comprehensive loss, net of tax (2.2 ) (30.5 ) (28.5 ) 59.0 (2.2 ) Comprehensive loss $ (4.8 ) $ (3.4 ) $ (13.7 ) $ 17.1 $ (4.8 ) WELBILT, INC. Consolidating Balance Sheet (Unaudited) (in millions) March 31, 2020 Parent Guarantor Non- Consolidating Adjustments Consolidated Assets Current assets: Cash and cash equivalents $ 42.0 $ (0.9 ) $ 107.4 $ — $ 148.5 Accounts receivable — net — 81.8 108.2 — 190.0 Inventories — net — 108.8 92.1 — 200.9 Prepaids and other current assets 24.5 3.7 18.3 — 46.5 Total current assets 66.5 193.4 326.0 — 585.9 Property, plant and equipment — net 14.3 70.0 40.3 — 124.6 Operating lease right-of-use assets 0.1 4.7 33.5 — 38.3 Goodwill — 832.4 97.3 — 929.7 Other intangible assets — net 0.2 337.0 144.7 — 481.9 Intercompany long-term notes receivable — 10.1 9.9 (20.0 ) — Due from affiliates — 3,429.7 — (3,429.7 ) — Investment in subsidiaries 4,406.0 — — (4,406.0 ) — Other non-current assets 4.9 3.8 15.9 — 24.6 Total assets $ 4,492.0 $ 4,881.1 $ 667.6 $ (7,855.7 ) $ 2,185.0 Liabilities and equity Current liabilities: Trade accounts payable $ 0.3 $ 52.8 $ 60.7 $ — $ 113.8 Accrued expenses and other liabilities 20.2 63.1 58.0 — 141.3 Current portion of long-term debt and finance leases 0.9 0.6 0.4 — 1.9 Product warranties — 20.7 11.2 — 31.9 Total current liabilities 21.4 137.2 130.3 — 288.9 Long-term debt and finance leases 1,475.2 0.6 30.3 — 1,506.1 Deferred income taxes 51.1 — 36.0 — 87.1 Pension and postretirement health liabilities 14.9 10.1 5.4 — 30.4 Intercompany long-term notes payable 15.6 — 4.6 (20.2 ) — Due to affiliates 2,694.6 — 735.0 (3,429.6 ) — Investment in subsidiaries — 305.2 — (305.2 ) — Operating lease liabilities — 2.3 25.2 — 27.5 Other long-term liabilities 6.3 19.7 6.0 — 32.0 Total non-current liabilities 4,257.7 337.9 842.5 (3,755.0 ) 1,683.1 Total equity (deficit) 212.9 4,406.0 (305.2 ) (4,100.7 ) 213.0 Total liabilities and equity $ 4,492.0 $ 4,881.1 $ 667.6 $ (7,855.7 ) $ 2,185.0 WELBILT, INC. Consolidating Balance Sheet (Audited) (in millions) December 31, 2019 Parent Guarantor Non- Consolidating Adjustments Consolidated Assets Current assets: Cash and cash equivalents $ 10.7 $ 0.7 $ 119.3 $ — $ 130.7 Accounts receivable — net 0.1 82.5 101.0 — 183.6 Intercompany trade receivable — 5.9 — (5.9 ) — Inventories — net — 100.2 86.2 — 186.4 Prepaids and other current assets 6.7 6.8 14.7 — 28.2 Total current assets 17.5 196.1 321.2 (5.9 ) 528.9 Property, plant and equipment — net 17.0 66.4 44.1 — 127.5 Operating lease right-of-use assets — 3.6 36.3 — 39.9 Goodwill — 832.4 100.7 — 933.1 Other intangible assets — net — 344.2 163.5 — 507.7 Intercompany long-term notes receivable — 10.1 9.9 (20.0 ) — Due from affiliates — 3,437.2 — (3,437.2 ) — Investment in subsidiaries 4,400.9 — — (4,400.9 ) — Other non-current assets 7.6 4.2 16.4 — 28.2 Total assets $ 4,443.0 $ 4,894.2 $ 692.1 $ (7,864.0 ) $ 2,165.3 Liabilities and equity Current liabilities: Trade accounts payable $ 0.2 $ 49.0 $ 55.2 $ — $ 104.4 Accrued expenses and other liabilities 35.3 87.7 69.4 — 192.4 Current portion of long-term debt and finance leases — 0.7 0.5 — 1.2 Intercompany trade payable 5.9 — — (5.9 ) — Product warranties — 21.9 11.4 — 33.3 Total current liabilities 41.4 159.3 136.5 (5.9 ) 331.3 Long-term debt and finance leases 1,370.0 0.6 32.5 — 1,403.1 Deferred income taxes 45.0 — 36.9 — 81.9 Pension and postretirement health liabilities 15.5 10.2 7.1 — 32.8 Intercompany long-term notes payable 15.7 — 4.3 (20.0 ) — Due to affiliates 2,695.1 — 742.1 (3,437.2 ) — Investment in subsidiaries — 300.9 — (300.9 ) — Operating lease liabilities — 1.8 27.3 — 29.1 Other long-term liabilities 7.4 20.5 6.3 (0.1 ) 34.1 Total non-current liabilities 4,148.7 334.0 856.5 (3,758.2 ) 1,581.0 Total equity (deficit) 252.9 4,400.9 (300.9 ) (4,099.9 ) 253.0 Total liabilities and equity $ 4,443.0 $ 4,894.2 $ 692.1 $ (7,864.0 ) $ 2,165.3 WELBILT, INC. Consolidating Statement of Cash Flows (Unaudited) (in millions) Three Months Ended March 31, 2020 Parent Guarantor Non- Consolidating Adjustments Consolidated Cash flows from operating activities Net cash (used in) provided by operating activities $ (69.7 ) $ (4.5 ) $ 1.7 $ — $ (72.5 ) Cash flows from investing activities Capital expenditures — (4.5 ) (1.1 ) — (5.6 ) Intercompany investment — 7.6 (7.1 ) (0.5 ) — Other (3.9 ) — — — (3.9 ) Net cash (used in) provided by investing activities (3.9 ) 3.1 (8.2 ) (0.5 ) (9.5 ) Cash flows from financing activities Proceeds from long-term debt 128.0 — — — 128.0 Repayments on long-term debt and finance leases (23.0 ) (0.2 ) (0.1 ) — (23.3 ) Exercises of stock options 1.1 — — — 1.1 Payments on tax withholdings for equity awards (0.7 ) — — — (0.7 ) Intercompany financing (0.5 ) — — 0.5 — Net cash provided by (used in) financing activities 104.9 (0.2 ) (0.1 ) 0.5 105.1 Effect of exchange rate changes on cash — — (5.3 ) — (5.3 ) Net increase (decrease) in cash and cash equivalents and restricted cash 31.3 (1.6 ) (11.9 ) — 17.8 Balance at beginning of period 10.7 0.7 119.3 — 130.7 Balance at end of period $ 42.0 $ (0.9 ) $ 107.4 $ — $ 148.5 WELBILT, INC. Consolidating Statement of Cash Flows (Unaudited) (in millions) Three Months Ended March 31, 2019 Parent Guarantor Non- Consolidating Adjustments Consolidated Cash flows from operating activities Net cash used in operating activities $ (62.5 ) $ (138.2 ) $ (154.0 ) $ (2.3 ) $ (357.0 ) Cash flows from investing activities Cash receipts on beneficial interest in sold receivables — 35.6 160.4 — 196.0 Capital expenditures (1.7 ) (2.4 ) (0.7 ) — (4.8 ) Intercompany investment — 105.6 (8.9 ) (96.7 ) — Other 0.2 — — — 0.2 Net cash (used in) provided by investing activities (1.5 ) 138.8 150.8 (96.7 ) 191.4 Cash flows from financing activities Proceeds from long-term debt 196.5 — — — 196.5 Repayments on long-term debt and finance leases (32.5 ) (0.3 ) — — (32.8 ) Repayment of short-term borrowings — — (15.0 ) — (15.0 ) Payment of contingent consideration — (0.8 ) — — (0.8 ) Exercises of stock options 0.6 — — — 0.6 Payments on tax withholdings for equity awards (1.8 ) — — — (1.8 ) Intercompany financing (96.8 ) — — 96.8 — Net cash provided by (used in) financing activities 66.0 (1.1 ) (15.0 ) 96.8 146.7 Effect of exchange rate changes on cash — — 1.0 — 1.0 Net increase (decrease) in cash and cash equivalents and restricted cash 2.0 (0.5 ) (17.2 ) (2.2 ) (17.9 ) Balance at beginning of period 0.2 0.5 72.5 — 73.2 Balance at end of period $ 2.2 $ — $ 55.3 $ (2.2 ) $ 55.3

Subsequent Event

Subsequent Event	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Event	Subsequent Event Amendment to 2016 Credit Facility On April 17, 2020, the Company entered into Amendment No. 7 (the “Amendment”) to the 2016 Credit Agreement, to amend the financial covenants of the Revolving Credit Facility. The terms of the Amendment, among other items, (i) suspend the Consolidated Total Leverage Ratio and Consolidated Interest Coverage Ratio covenants, in each case, as defined in the 2016 Credit Agreement, for four fiscal quarters until March 31, 2021 ("Suspension Period") and (ii) temporarily replace the suspended covenants with a Minimum Consolidated EBITDA covenant and a Maximum Capital Expenditure covenant, each computed on a trailing four quarters basis and measured quarterly and a Minimum Liquidity covenant that is measured monthly, each as defined in the Amendment, throughout the Suspension Period, with the Minimum Liquidity covenant extending through June 30, 2021. Beginning in the second quarter of 2021, the Consolidated Total Leverage Ratio and Consolidated Interest Coverage Ratio covenants will be reinstated at modified levels as compared to the covenants in effect as of March 31, 2020 and will return to the March 31, 2020 covenant levels by the fourth quarter of 2021. The Amendment prohibits draws under the Revolving Credit Facility (i) if the Company has not evidenced compliance with the financial covenants for the year ended December 31, 2021 by delivery of a compliance certificate within 90 days, and ii) to the extent the draw would result in a consolidated cash balance of $100 million or greater (excluding cash held in China) through December 31, 2021, with the exception of draws to meet cash uses anticipated in the ordinary course of business that are expected to be paid within 10 days of the draw. The Amendment also includes additional limitations on restricted payments, investments and other actions that are otherwise allowed under the 2016 Credit Agreement, with a $25.0 million carve-out for a general investments basket. These limitations expire on December 31, 2021. The Amendment includes a quarterly fee applicable through the fourth quarter of 2021 in an amount equal to a per annum rate of 0.50% on the average outstanding balance of the Revolving Credit Facility payable on a quarterly basis. The Company estimates total debt issuance costs in connection with this Amendment to be approximately $2.3 million , which will be capitalized and included as a component of "Other non-current assets" on the Company's Consolidated Balance Sheets and amortized using the effective interest method through the maturity of the Revolving Credit Facility in October 2023.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Principles of Consolidation and Basis of Presentation	The accompanying unaudited consolidated financial statements include the accounts of Welbilt and its subsidiaries and have been prepared by the Company, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). The Company prepares its financial statements in accordance with accounting principles generally accepted in the U.S. ("U.S. GAAP"). All intercompany balances and transactions between the Company and its affiliates have been eliminated in consolidation.
Use of Estimates	The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant items subject to such estimates and assumptions include inventory obsolescence costs, asset impairments, warranty costs, product liability costs, employee benefit programs, sales rebates, loss contingencies and the measurement of income tax assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On an ongoing basis, the Company evaluates these assumptions, judgments and estimates. Actual results may differ from these estimates.
Recently Adopted and Not Yet Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In August 2018, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2018-15, "Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract," which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software, with amortization expense being recorded in the same income statement expense line as the hosted service costs and over the expected term of the hosting arrangement. This standard was effective for the Company on January 1, 2020 and has been adopted prospectively for applicable implementation costs incurred subsequent to the effective date. In June 2016, the FASB issued ASU 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," including subsequent amendments issued thereafter which clarify the standard (collectively, "Topic 326"), which significantly changes the impairment model for most financial instruments. Current guidance requires the recognition of credit losses based on an incurred loss impairment methodology that reflects losses once the losses are probable. In accordance with Topic 326, the Company will be required to use a current expected credit loss model (“CECL”) that will immediately recognize an estimate of credit losses that are expected to occur over the life of the financial instruments that are within the scope of this update, including trade receivables. The CECL model uses a broader range of reasonable and supportable information in the development of credit loss estimates. This standard was effective for the Company on January 1, 2020 and, upon adoption, the Company recorded an additional expected credit loss allowance with an offsetting adjustment to retained earnings of $0.4 million . In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting" ("ASU 2020-04") to provide temporary optional expedients and exceptions to U.S. GAAP guidance on contract modifications, hedge accounting and other transactions affected by the expected market transition from the London Interbank Offered Rate ("LIBOR") and other interbank offered rates to alternative reference rates. ASU 2020-04 is effective upon issuance and the Company may elect to apply the standard through December 31, 2022. This guidance primarily impacts the interest expense under the Company's 2016 Credit Facility which utilizes LIBOR as a basis. As the Company has not completed a modification of the interest component of this financial instrument and does not have related outstanding hedges in place as of March 31, 2020, the guidance has not impacted the Company's consolidated financial statements to date. The Company will evaluate the impact of adopting this guidance at the time such transition to an alternative reference rate occurs. Recently Issued Accounting Pronouncements Not Yet Adopted In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes" ("ASU 2019-12"), which amends, and is intended to simplify, existing guidance related to the accounting for income taxes. ASU 2019-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. This guidance is effective for the Company beginning January 1, 2021. The Company is currently evaluating the impact this new standard will have on the Company's consolidated financial statements. Recent accounting guidance not discussed is not applicable, did not have, or is not expected to have a material impact on the Company.

Inventories - Net (Tables)

Inventories - Net (Tables)	3 Months Ended
	Mar. 31, 2020
Inventory Disclosure [Abstract]
Components of Inventories	The components of "Inventories — net" are as follows: (in millions) March 31, December 31, 2020 2019 Inventories — net: Raw materials $ 84.0 $ 81.4 Work-in-process 14.8 14.2 Finished goods 106.3 95.0 Total inventories at FIFO cost 205.1 190.6 Excess of FIFO costs over LIFO value (4.2 ) (4.2 ) Total inventories — net $ 200.9 $ 186.4

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets - Net (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in the Carrying Amount of Goodwill by Geographic Segment	The changes in the carrying amount of goodwill by geographic business segment are as follows: (in millions) Americas EMEA APAC Total Gross balance as of December 31, 2019 $ 1,144.8 $ 284.1 $ 19.9 $ 1,448.8 Accumulated asset impairments (312.2 ) (203.5 ) — (515.7 ) Net balance as of December 31, 2019 $ 832.6 $ 80.6 $ 19.9 $ 933.1 Foreign currency impact $ — $ (2.8 ) $ (0.6 ) $ (3.4 ) Gross balance as of March 31, 2020 1,144.8 281.3 19.3 1,445.4 Accumulated asset impairments (312.2 ) (203.5 ) — (515.7 ) Net balance as of March 31, 2020 $ 832.6 $ 77.8 $ 19.3 $ 929.7
Changes in Gross Carrying Amount and Balances of Finite-Lived Intangible Assets	The gross carrying amounts, impairment charges and accumulated amortization of the Company's intangible assets, other than goodwill, are as follows: (in millions) March 31, 2020 December 31, 2019 Gross Impairment Charges Accumulated Net Gross Accumulated Net Customer relationships $ 470.7 $ — $ (249.8 ) $ 220.9 $ 472.8 $ (243.6 ) $ 229.2 Trademarks and trade names 214.8 (11.1 ) — 203.7 217.6 — 217.6 Other intangibles 165.7 — (112.2 ) 53.5 166.9 (109.8 ) 57.1 Patents 5.8 — (2.0 ) 3.8 5.8 (2.0 ) 3.8 Total $ 857.0 $ (11.1 ) $ (364.0 ) $ 481.9 $ 863.1 $ (355.4 ) $ 507.7
Changes in Gross Carrying Amount and Balances of Indefinite-Lived Intangible Assets	The gross carrying amounts, impairment charges and accumulated amortization of the Company's intangible assets, other than goodwill, are as follows: (in millions) March 31, 2020 December 31, 2019 Gross Impairment Charges Accumulated Net Gross Accumulated Net Customer relationships $ 470.7 $ — $ (249.8 ) $ 220.9 $ 472.8 $ (243.6 ) $ 229.2 Trademarks and trade names 214.8 (11.1 ) — 203.7 217.6 — 217.6 Other intangibles 165.7 — (112.2 ) 53.5 166.9 (109.8 ) 57.1 Patents 5.8 — (2.0 ) 3.8 5.8 (2.0 ) 3.8 Total $ 857.0 $ (11.1 ) $ (364.0 ) $ 481.9 $ 863.1 $ (355.4 ) $ 507.7

Property, Plant and Equipment_2

Property, Plant and Equipment - Net (Tables)	3 Months Ended
	Mar. 31, 2020
Property, Plant and Equipment [Abstract]
Components of Property, Plant and Equipment	The components of "Property, plant and equipment — net" are as follows: (in millions) March 31, December 31, 2020 2019 Property, plant and equipment — net: Land $ 9.6 $ 9.7 Building and improvements 92.7 93.2 Machinery, equipment and tooling 220.9 223.3 Furniture and fixtures 7.4 7.6 Computer hardware and software for internal use 65.4 66.1 Construction in progress 21.5 22.0 Total cost 417.5 421.9 Less accumulated depreciation (292.9 ) (294.4 ) Total property, plant and equipment — net $ 124.6 $ 127.5

Accrued Expenses and Other Li_2

Accrued Expenses and Other Liabilities (Tables)	3 Months Ended
	Mar. 31, 2020
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Liabilities	"Accrued expenses and other liabilities" are as follows: (in millions) March 31, December 31, 2020 2019 Accrued expenses and other liabilities: Accrued rebates and commissions $ 32.6 $ 56.2 Miscellaneous accrued expenses 34.9 37.8 Employee related expenses 27.9 34.7 Interest payable 5.7 15.8 Operating lease liabilities 10.1 10.0 Restructuring liabilities 7.4 6.3 Business Transformation Program related expenses 4.1 5.8 Derivative liabilities 1.8 5.0 Income and other taxes payable 7.7 11.2 Deferred revenues 2.7 3.1 Customer deposits 2.9 3.1 Pension and postretirement health liabilities 2.1 2.1 Product liabilities 1.4 1.3 Total accrued expenses and other liabilities $ 141.3 $ 192.4

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Schedule of Outstanding Debt	The carrying value of the Company's outstanding debt consists of the following: (in millions, except percentage data) March 31, 2020 December 31, 2019 Carrying Value Weighted Average Interest Rate Carrying Value Weighted Average Interest Rate Long-term debt and finance leases: Revolving Credit Facility $ 244.9 4.37 % $ 141.8 5.00 % Term Loan B Facility 855.0 4.50 % 855.0 5.11 % 9.50% Senior Notes due 2024 425.0 9.72 % 425.0 9.72 % Finance leases 2.2 4.83 % 2.5 4.83 % Total debt and finance leases, including current portion 1,527.1 1,424.3 Less current portion: Term Loan B Facility (0.8 ) — Finance leases (1.1 ) (1.2 ) Unamortized debt issuance costs (1) (19.5 ) (20.5 ) Hedge accounting fair value adjustment (2) 0.4 0.5 Total long-term debt and finance leases $ 1,506.1 $ 1,403.1 (1) Total debt issuance costs, net of amortization as of March 31, 2020 and December 31, 2019 were $21.9 million and $23.0 million, respectively, of which $2.4 million and $2.5 million, respectively, are related to the Revolving Credit Facility (as defined below) and recorded in "Other non-current assets" in the Consolidated Balance Sheets. (2) Balance represents deferred gains from the terminations of interest rate swaps designated as fair value hedges.

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Outstanding Commodity and Currency Forward Contracts	The Company had the following outstanding commodity and currency forward contracts that were not designated as hedging instruments: Commodity Contracted Units Unit March 31, December 31, 2020 2019 Aluminum 392 524 MT Copper 189 269 MT Steel 908 1,778 Short tons Currency Contracted Units March 31, December 31, 2020 2019 Singapore Dollar 28,367,000 28,427,000 Euro 81,085,000 75,557,000 British Pound 26,488,585 20,323,932 Mexican Peso 13,500,000 11,805,000 Swiss Franc 6,400,000 7,000,000 Canadian Dollar 997,000 1,330,000 The Company's outstanding currency forward contracts entered into as hedges of forecasted transactions are as follows: Currency Units Hedged March 31, December 31, 2020 2019 Canadian Dollar 4,608,000 8,014,000 Euro 4,073,000 7,593,000 British Pound 4,342,932 8,046,471 Mexican Peso 65,150,000 111,250,000 Singapore Dollar 1,210,000 2,019,000
Schedule of Impact of Derivative Instruments on the Consolidated Statements of Comprehensive Income and the Consolidated Statements of Operations	The location and impact on the Consolidated Statements of Operations for gains or losses related to derivative instruments not designated as hedging instruments are as follows: Derivatives NOT designated as hedging instruments Amount of gain/(loss) recognized in income on derivative Location of gain/(loss) recognized in income on derivative (in millions) Three Months Ended March 31, 2020 2019 Foreign currency exchange contracts $ (2.0 ) $ 2.8 Other (income) expense — net Commodity contracts (0.5 ) — Other (income) expense — net Total $ (2.5 ) $ 2.8 The table below presents the effect of the Company’s derivative financial instruments on the Consolidated Statements of Operations : (in millions) Location and amount of gain/(loss) recognized on effect of fair value and cash flow derivative instruments Three Months Ended Three Months Ended March 31, 2020 March 31, 2019 Cost of Sales Interest Expense Cost of Sales Interest Expense Total amounts of expense line items presented in the Consolidated Statements of Operations in which effects of fair value and cash flow hedges are recorded $ 214.1 $ 21.3 $ 248.8 $ 24.0 The effects of fair value and cash flow hedging: Gain/(loss) on fair value hedging relationship: Interest rate contract: Hedged item $ — $ 0.1 $ — $ (7.0 ) Derivative designated as hedging instrument $ — $ — $ — $ 6.6 Gain/(loss) on cash flow hedging relationships: Foreign currency exchange contracts: Amount of gain/(loss) reclassified from AOCI into income $ (0.1 ) $ — $ (0.3 ) $ — Commodity contracts: Amount of gain/(loss) reclassified from AOCI into income $ (0.5 ) $ — $ (0.1 ) $ — Interest rate contracts: Amount of gain/(loss) reclassified from AOCI into income $ — $ — $ — $ 1.1 The effects of the Company's derivative instruments on the Consolidated Statements of Comprehensive Income and Consolidated Statements of Operations for gains or losses initially recognized in AOCI in the Consolidated Balance Sheets were as follows: Derivatives in cash flow hedging relationships Pretax gain/(loss) recognized in AOCI Pretax gain/(loss) reclassified from AOCI into income (in millions) Three Months Ended March 31, Location Three Months Ended March 31, 2020 2019 2020 2019 Foreign currency exchange contracts $ (1.1 ) $ (0.1 ) Cost of sales $ (0.1 ) $ (0.3 ) Commodity contracts — 0.2 Cost of sales (0.5 ) (0.1 ) Interest rate swap contracts — (0.6 ) Interest expense — 1.1 Total $ (1.1 ) $ (0.5 ) $ (0.6 ) $ 0.7 The location and effects of the net investment hedge on the Consolidated Statements of Comprehensive Income and Consolidated Statements of Operations were as follows: Derivative in net investment hedging relationship Pretax gain/(loss) recognized in AOCI Gain/(loss) reclassified from AOCI into income Gain/(loss) recognized in income (amount excluded from effectiveness testing) (in millions) Three Months Ended Location Three Months Ended Location Three Months Ended March 31, March 31, March 31, 2020 2019 2020 2019 2020 2019 Interest rate swap contract $ (0.8 ) $ 1.6 N/A $ — $ — Other (income) expense — net $ 0.3 $ 0.4
Schedule of the Fair Value of Outstanding Derivative Contracts Recorded as Assets in the Accompanying Consolidated Balance Sheet	The fair value of outstanding derivative contracts recorded as assets in the Consolidated Balance Sheets are as follows: (in millions) Balance Sheet Location Asset Derivatives Fair Value March 31, December 31, 2020 2019 Derivatives designated as hedging instruments: Foreign currency exchange contracts Prepaids and other current assets $ — $ 0.8 Total derivatives designated as hedging instruments $ — $ 0.8 Derivatives NOT designated as hedging instruments: Foreign currency exchange contracts Prepaids and other current assets $ 0.6 $ 0.4 Total derivatives NOT designated as hedging instruments $ 0.6 $ 0.4 Total asset derivatives $ 0.6 $ 1.2
Schedule of the Fair Value of Outstanding Derivative Contracts Recorded as Liabilities in the Accompanying Consolidated Balance Sheet	The fair value of outstanding derivative contracts recorded as liabilities in the Consolidated Balance Sheets are as follows: (in millions) Balance Sheet Location Liability Derivatives Fair Value March 31, December 31, 2020 2019 Derivatives designated as hedging instruments: Foreign currency exchange contracts Accrued expenses and other liabilities $ 0.8 $ 0.6 Interest rate swap contracts Accrued expenses and other liabilities — 3.2 Total derivatives designated as hedging instruments $ 0.8 $ 3.8 Derivatives NOT designated as hedging instruments: Foreign currency exchange contracts Accrued expenses and other liabilities $ 0.3 $ 0.6 Commodity contracts Accrued expenses and other liabilities 0.7 0.6 Total derivatives NOT designated as hedging instruments $ 1.0 $ 1.2 Total liability derivatives $ 1.8 $ 5.0

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Financial Assets and Liabilities Accounted for at Fair Value on a Recurring Basis by level within the Fair Value Hierarchy	The following tables set forth financial assets and liabilities that were accounted for at fair value on a recurring basis by level within the fair value hierarchy. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement: (in millions) Fair Value March 31, 2020 Level 1 Level 2 Level 3 Total Current assets: Foreign currency exchange contracts $ — $ 0.6 $ — $ 0.6 Total current assets at fair value — 0.6 — 0.6 Total assets at fair value $ — $ 0.6 $ — $ 0.6 Current liabilities: Foreign currency exchange contracts $ — $ 1.1 $ — $ 1.1 Commodity contracts — 0.7 — 0.7 Total current liabilities at fair value — 1.8 — 1.8 Total liabilities at fair value $ — $ 1.8 $ — $ 1.8 (in millions) Fair Value December 31, 2019 Level 1 Level 2 Level 3 Total Current assets: Foreign currency exchange contracts $ — $ 1.2 $ — $ 1.2 Total current assets at fair value — 1.2 — 1.2 Total assets at fair value $ — $ 1.2 $ — $ 1.2 Current liabilities: Foreign currency exchange contracts $ — $ 1.2 $ — $ 1.2 Commodity contracts — 0.6 — 0.6 Interest rate swap contracts — 3.2 — 3.2 Total current liabilities at fair value — 5.0 — 5.0 Total liabilities at fair value $ — $ 5.0 $ — $ 5.0

Product Warranties (Tables)

Product Warranties (Tables)	3 Months Ended
	Mar. 31, 2020
Guarantees and Product Warranties [Abstract]
Schedule of the Summary of Product Warranty Activity	The product warranty liability activity for the three months ended March 31, 2020 is as follows: (in millions) Balance as of December 31, 2019 (1) $ 43.9 Additions for issuance of warranties 8.4 Settlements (in cash or in kind) (9.5 ) Currency translation impact (0.8 ) Balance as of March 31, 2020 (1) $ 42.0 (1) Long-term product warranty liabilities are included in "Other long-term liabilities" and totaled $10.1 million and $10.6 million as of March 31, 2020 and December 31, 2019, respectively.

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	3 Months Ended
	Mar. 31, 2020
Retirement Benefits [Abstract]
Schedule of Components of Period Benefit Costs	The components of the periodic benefit costs for the defined benefit plans are as follows: (in millions) Three Months Ended March 31, 2020 2019 Pension Plans Postretirement Pension Plans Postretirement Interest cost of projected benefit obligations $ 1.0 $ — $ 1.3 $ 0.1 Expected return on assets (1.0 ) — (1.2 ) — Amortization of prior service cost — (0.1 ) — — Amortization of actuarial net loss 0.6 0.2 0.5 0.1 Settlement loss recognized — — 1.2 — Net periodic benefit cost $ 0.6 $ 0.1 $ 1.8 $ 0.2

Business Transformation Progr_2

Business Transformation Program and Restructuring (Tables)	3 Months Ended
	Mar. 31, 2020
Restructuring and Related Activities [Abstract]
Components of Transformation Program expense	The components of Transformation Program expense incurred are as follows: (in millions) Three Months Ended March 31, 2020 2019 Transformation Program expense: Cost of sales $ 0.8 $ — Selling, general and administrative expenses 10.8 5.8 Total $ 11.6 $ 5.8
Rollforward of all Restructuring Activities	The Company's restructuring activity and balance of the restructuring liability is as follows: (in millions) 2020 Plans 2019 and Previous Plans Total Workforce reductions Workforce reductions Other Pension withdrawal obligation Restructuring liability as of December 31, 2019 $ — $ 5.0 $ — $ 9.9 $ 14.9 Restructuring activities 2.8 0.8 0.1 — 3.7 Cash payments (0.4 ) (2.0 ) — (0.3 ) (2.7 ) Non-cash adjustments (1) (0.1 ) — (0.1 ) — (0.2 ) Restructuring liability as of March 31, 2020 $ 2.3 $ 3.8 $ — $ 9.6 $ 15.7 ( 1) Non-cash adjustments represent stock-based compensation resulting from the accelerated vesting of certain stock awards and accelerated depreciation recorded during the period.
Restructuring Expense by Segment	The Company's restructuring expense by segment is as follows: (in millions) Three Months Ended March 31, 2020 2019 Americas $ 2.2 $ 1.7 EMEA 0.3 0.4 APAC 0.5 0.1 Corporate 0.7 2.0 Total restructuring activities $ 3.7 $ 4.2 The Company's restructuring expense is reported as follows in the Consolidated Statements of Operations : (in millions) Three Months Ended March 31, 2020 2019 Cost of sales $ 0.1 $ — Restructuring and other expenses 3.6 4.2 Total restructuring activities $ 3.7 $ 4.2

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Reconciliations for the Changes in Accumulated Other Comprehensive Loss	The components of the Company's AOCI are as follows: (in millions) March 31, December 31, 2020 2019 Accumulated other comprehensive loss: Foreign currency translation, net of income tax benefit of $0.9 million and $1.6 million, respectively $ (32.5 ) $ (4.3 ) Derivative instrument fair market value, net of income tax expense of $0.7 million and $0.8 million, respectively (2.0 ) (1.6 ) Employee pension and postretirement benefit adjustments, net of income tax benefit of $6.4 million and $6.5 million, respectively (33.6 ) (35.6 ) Total accumulated other comprehensive loss $ (68.1 ) $ (41.5 ) The summary of changes in AOCI for the three months ended March 31, 2020 and 2019 are as follows: (in millions) Foreign Currency Translation (1) Gains and Losses on Cash Flow Hedges Pension & Postretirement Total Balance as of December 31, 2019 $ (4.3 ) $ (1.6 ) $ (35.6 ) $ (41.5 ) Other comprehensive (loss) income before reclassifications (27.5 ) (1.1 ) 1.4 (27.2 ) Reclassifications — 0.6 0.7 1.3 Tax effect (0.7 ) 0.1 (0.1 ) (0.7 ) Net current period other comprehensive (loss) income (28.2 ) (0.4 ) 2.0 (26.6 ) Balance as of March 31, 2020 $ (32.5 ) $ (2.0 ) $ (33.6 ) $ (68.1 ) (in millions) Foreign Currency Translation (1) Gains and Losses on Cash Flow Hedges Pension & Postretirement Total Balance as of December 31, 2018 $ (6.5 ) $ 0.8 $ (35.9 ) $ (41.6 ) Other comprehensive income (loss) before reclassifications 0.3 (0.5 ) (2.9 ) (3.1 ) Reclassifications — (0.7 ) 1.8 1.1 Tax effect (0.3 ) 0.2 (0.1 ) (0.2 ) Net current period other comprehensive loss — (1.0 ) (1.2 ) (2.2 ) Balance as of March 31, 2019 $ (6.5 ) $ (0.2 ) $ (37.1 ) $ (43.8 ) (1) Income taxes are not provided for foreign currency translation relating to indefinite investments in foreign subsidiaries, although the income tax effects within cumulative translation does include the impact of the net investment hedge transaction through its expiration in March 2020. Reclassification adjustments are made to avoid including items in both comprehensive income and net earnings.
Reclassification out of Accumulated Other Comprehensive Loss	Reclassifications from AOCI, net of tax, to income were as follows: (in millions) Three Months Ended March 31, Recognized Location 2020 2019 (Losses) gains on cash flow hedges: Foreign currency exchange contracts $ (0.1 ) $ (0.3 ) Cost of sales Commodity contracts (0.5 ) (0.1 ) Cost of sales Interest expense — 1.1 Interest expense (Losses) gains on cash flow hedges, before tax (0.6 ) 0.7 Tax effect 0.1 0.1 Income taxes (Losses) gains on cash flow hedges, net of tax $ (0.5 ) $ 0.8 Amortization of pension and postretirement items: Amortization of prior service cost $ 0.1 $ — Other (income) expense — net Actuarial losses (0.8 ) (0.6 ) Other (income) expense — net Pension settlement — (1.2 ) Other (income) expense — net Amortization of pension and postretirement items, before tax (0.7 ) (1.8 ) Tax effect 0.1 0.1 Income taxes Amortization of pension and postretirement items, net of tax $ (0.6 ) $ (1.7 ) Total reclassifications, net of tax $ (1.1 ) $ (0.9 )

Loss Per Share (Tables)

Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Schedule of Antidilutive Potential Shares Of Common Stock	The following table summarizes the number of shares of common stock issuable pursuant to the Company's outstanding stock-based compensation awards that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average market price of the common shares: March 31, March 31, 2020 2019 Potential shares of common stock: Stock options 2,372,495 2,232,634 Unvested restricted stock units 575,758 438,978 Unvested performance share units (1) 691,494 617,068 Total potential shares of common stock 3,639,747 3,288,680 (1) The number of performance share units that vest is determined for each grant based on the achievement of certain Company performance criteria over the 3 -year period, as set forth in each respective award agreement, and may range from zero to 200% of the target shares granted. The unvested performance share units are presented at 100% achievement of the performance target for determination of potential shares of common stock.

Business Segments (Tables)

Business Segments (Tables)	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Schedule of Financial Information Relating to the Company's Reportable Segments	Financial information relating to the Company's geographic business segments is as follows: (in millions, except percentage data) Three Months Ended March 31, 2020 2019 Net sales: Americas $ 250.5 $ 275.1 EMEA 90.0 106.7 APAC 51.3 54.8 Elimination of intersegment sales (62.9 ) (61.3 ) Total net sales $ 328.9 $ 375.3 Segment Adjusted Operating EBITDA: Americas $ 52.3 $ 44.5 EMEA 13.6 18.2 APAC 8.2 7.9 Total Segment Adjusted Operating EBITDA 74.1 70.6 Corporate and unallocated expenses (28.6 ) (20.5 ) Amortization expense (10.0 ) (9.5 ) Depreciation expense (5.2 ) (4.9 ) Transaction costs (1) (0.1 ) (0.4 ) Other items (2) (3.1 ) (0.8 ) Transformation Program expense (3) (11.6 ) (5.8 ) Restructuring activities (4) (3.7 ) (4.2 ) Loss from impairment and disposal of assets — net (11.2 ) — Earnings from operations 0.6 24.5 Interest expense (21.3 ) (24.0 ) Other income (expense) — net 5.4 (3.0 ) Loss before income taxes $ (15.3 ) $ (2.5 ) (1) Transaction costs are associated with acquisition-related transaction and integration activities. Transaction costs recorded in "Cost of Sales" include $0.2 million related to inventory fair value purchase accounting adjustments for the three months ended March 31, 2019. Professional services and other direct acquisition and integration costs recorded in "Selling, general and administrative expenses" were $0.1 million and $0.2 million for the three months ended March 31, 2020 and 2019, respectively. (2) Other items are costs which are not representative of the Company's operational performance. For the three months ended March 31, 2020, other items represent the loss contingency estimate of amounts due for custom duties, fees and interest on previously imported products, which are included in "Restructuring and other expenses." Refer to Note 12, "Contingencies and Significant Estimates" for discussion of the impact to the Consolidated Statements of Operations. For the three months ended March 31, 2019, the amount represents other professional fees which are included in "Selling, general and administrative expenses." (3) Transformation Program expense includes consulting and other costs associated with executing the Company's Transformation Program initiatives. Refer to Note 15, "Business Transformation Program and Restructuring" for discussion of the impact to the Consolidated Statements of Operations. (4) Restructuring activities includes costs associated with actions to improve operating efficiencies and rationalization of the Company's cost structure. Refer to Note 15, "Business Transformation Program and Restructuring" for discussion of the impact to the Consolidated Statements of Operations. Adjusted Operating EBITDA % by segment (5) : Americas 20.9 % 16.2 % EMEA 15.1 % 17.1 % APAC 16.0 % 14.4 % (5) Adjusted Operating EBITDA % is calculated by dividing Adjusted Operating EBITDA by net sales for each respective segment. (in millions) Three Months Ended March 31, 2020 2019 Third-party net sales by geographic area (6) : United States $ 204.4 $ 225.0 Other Americas 18.5 20.3 EMEA 69.2 88.6 APAC 36.8 41.4 Total net sales by geographic area $ 328.9 $ 375.3 (6) Net sales in the section above are attributed to geographic regions based on location of customer. Net sales by product class and geographic business segment are as follows: (in millions) Three Months Ended March 31, 2020 Commercial Foodservice Equipment Aftermarket Parts and Support Total Americas $ 182.0 $ 36.1 $ 218.1 EMEA 56.0 15.6 71.6 APAC 32.0 7.2 39.2 Total net sales $ 270.0 $ 58.9 $ 328.9 (in millions) Three months ended March 31, 2019 Commercial Foodservice Equipment Aftermarket Parts and Support Total Americas $ 202.6 $ 38.2 $ 240.8 EMEA 77.5 13.4 90.9 APAC 36.0 7.6 43.6 Total net sales $ 316.1 $ 59.2 $ 375.3 Total assets by geographic segment are as follows: (in millions) March 31, December 31, 2020 2019 Americas $ 1,529.1 $ 1,528.0 EMEA 336.0 349.8 APAC 202.3 211.8 Corporate 117.6 75.7 Total assets $ 2,185.0 $ 2,165.3

Subsidiary Guarantors and Sen_2

Subsidiary Guarantors and Senior Notes (Tables)	3 Months Ended
	Mar. 31, 2020
Condensed Financial Information Disclosure [Abstract]
Consolidating Statement of Operations	WELBILT, INC. Consolidating Statement of Operations (Unaudited) (in millions) Three Months Ended March 31, 2020 Parent Guarantor Non- Consolidating Adjustments Consolidated Net sales $ — $ 233.1 $ 210.9 $ (115.1 ) $ 328.9 Cost of sales — 170.0 159.2 (115.1 ) 214.1 Gross profit — 63.1 51.7 — 114.8 Selling, general and administrative expenses 18.1 32.8 35.6 — 86.5 Amortization expense — 7.1 2.6 — 9.7 Restructuring and other expenses 0.7 4.8 1.3 — 6.8 Loss from impairment and disposal of assets — net — — 11.2 — 11.2 (Loss) earnings from operations (18.8 ) 18.4 1.0 — 0.6 Interest expense 20.8 0.2 0.3 — 21.3 Other (income) expense — net (4.1 ) (6.3 ) 5.0 — (5.4 ) Equity in earnings (loss) of subsidiaries 5.0 (4.4 ) — (0.6 ) — (Loss) earnings before income taxes (30.5 ) 20.1 (4.3 ) (0.6 ) (15.3 ) Income taxes (15.4 ) 15.1 0.1 — (0.2 ) Net (loss) earnings $ (15.1 ) $ 5.0 $ (4.4 ) $ (0.6 ) $ (15.1 ) Total other comprehensive loss, net of tax (26.6 ) (25.0 ) (24.6 ) 49.6 (26.6 ) Comprehensive loss $ (41.7 ) $ (20.0 ) $ (29.0 ) $ 49.0 $ (41.7 ) WELBILT, INC. Consolidating Statement of Operations (Unaudited) (in millions) Three months ended March 31, 2019 Parent Guarantor Non- Consolidating Adjustments Consolidated Net sales $ — $ 247.2 $ 231.0 $ (102.9 ) $ 375.3 Cost of sales 1.0 188.6 162.1 (102.9 ) 248.8 Gross profit (1.0 ) 58.6 68.9 — 126.5 Selling, general and administrative expenses 20.6 35.3 32.4 — 88.3 Amortization expense — 7.1 2.4 — 9.5 Restructuring and other expenses 1.5 1.3 1.4 — 4.2 (Loss) earnings from operations (23.1 ) 14.9 32.7 — 24.5 Interest expense 21.8 0.2 2.0 — 24.0 Other (income) expense — net (6.4 ) (0.7 ) 10.1 — 3.0 Equity in earnings of subsidiaries 27.1 14.8 — (41.9 ) — (Loss) earnings before income taxes (11.4 ) 30.2 20.6 (41.9 ) (2.5 ) Income taxes (8.8 ) 3.1 5.8 — 0.1 Net (loss) earnings $ (2.6 ) $ 27.1 $ 14.8 $ (41.9 ) $ (2.6 ) Total other comprehensive loss, net of tax (2.2 ) (30.5 ) (28.5 ) 59.0 (2.2 ) Comprehensive loss $ (4.8 ) $ (3.4 ) $ (13.7 ) $ 17.1 $ (4.8 )
Consolidating Balance Sheet	WELBILT, INC. Consolidating Balance Sheet (Unaudited) (in millions) March 31, 2020 Parent Guarantor Non- Consolidating Adjustments Consolidated Assets Current assets: Cash and cash equivalents $ 42.0 $ (0.9 ) $ 107.4 $ — $ 148.5 Accounts receivable — net — 81.8 108.2 — 190.0 Inventories — net — 108.8 92.1 — 200.9 Prepaids and other current assets 24.5 3.7 18.3 — 46.5 Total current assets 66.5 193.4 326.0 — 585.9 Property, plant and equipment — net 14.3 70.0 40.3 — 124.6 Operating lease right-of-use assets 0.1 4.7 33.5 — 38.3 Goodwill — 832.4 97.3 — 929.7 Other intangible assets — net 0.2 337.0 144.7 — 481.9 Intercompany long-term notes receivable — 10.1 9.9 (20.0 ) — Due from affiliates — 3,429.7 — (3,429.7 ) — Investment in subsidiaries 4,406.0 — — (4,406.0 ) — Other non-current assets 4.9 3.8 15.9 — 24.6 Total assets $ 4,492.0 $ 4,881.1 $ 667.6 $ (7,855.7 ) $ 2,185.0 Liabilities and equity Current liabilities: Trade accounts payable $ 0.3 $ 52.8 $ 60.7 $ — $ 113.8 Accrued expenses and other liabilities 20.2 63.1 58.0 — 141.3 Current portion of long-term debt and finance leases 0.9 0.6 0.4 — 1.9 Product warranties — 20.7 11.2 — 31.9 Total current liabilities 21.4 137.2 130.3 — 288.9 Long-term debt and finance leases 1,475.2 0.6 30.3 — 1,506.1 Deferred income taxes 51.1 — 36.0 — 87.1 Pension and postretirement health liabilities 14.9 10.1 5.4 — 30.4 Intercompany long-term notes payable 15.6 — 4.6 (20.2 ) — Due to affiliates 2,694.6 — 735.0 (3,429.6 ) — Investment in subsidiaries — 305.2 — (305.2 ) — Operating lease liabilities — 2.3 25.2 — 27.5 Other long-term liabilities 6.3 19.7 6.0 — 32.0 Total non-current liabilities 4,257.7 337.9 842.5 (3,755.0 ) 1,683.1 Total equity (deficit) 212.9 4,406.0 (305.2 ) (4,100.7 ) 213.0 Total liabilities and equity $ 4,492.0 $ 4,881.1 $ 667.6 $ (7,855.7 ) $ 2,185.0 WELBILT, INC. Consolidating Balance Sheet (Audited) (in millions) December 31, 2019 Parent Guarantor Non- Consolidating Adjustments Consolidated Assets Current assets: Cash and cash equivalents $ 10.7 $ 0.7 $ 119.3 $ — $ 130.7 Accounts receivable — net 0.1 82.5 101.0 — 183.6 Intercompany trade receivable — 5.9 — (5.9 ) — Inventories — net — 100.2 86.2 — 186.4 Prepaids and other current assets 6.7 6.8 14.7 — 28.2 Total current assets 17.5 196.1 321.2 (5.9 ) 528.9 Property, plant and equipment — net 17.0 66.4 44.1 — 127.5 Operating lease right-of-use assets — 3.6 36.3 — 39.9 Goodwill — 832.4 100.7 — 933.1 Other intangible assets — net — 344.2 163.5 — 507.7 Intercompany long-term notes receivable — 10.1 9.9 (20.0 ) — Due from affiliates — 3,437.2 — (3,437.2 ) — Investment in subsidiaries 4,400.9 — — (4,400.9 ) — Other non-current assets 7.6 4.2 16.4 — 28.2 Total assets $ 4,443.0 $ 4,894.2 $ 692.1 $ (7,864.0 ) $ 2,165.3 Liabilities and equity Current liabilities: Trade accounts payable $ 0.2 $ 49.0 $ 55.2 $ — $ 104.4 Accrued expenses and other liabilities 35.3 87.7 69.4 — 192.4 Current portion of long-term debt and finance leases — 0.7 0.5 — 1.2 Intercompany trade payable 5.9 — — (5.9 ) — Product warranties — 21.9 11.4 — 33.3 Total current liabilities 41.4 159.3 136.5 (5.9 ) 331.3 Long-term debt and finance leases 1,370.0 0.6 32.5 — 1,403.1 Deferred income taxes 45.0 — 36.9 — 81.9 Pension and postretirement health liabilities 15.5 10.2 7.1 — 32.8 Intercompany long-term notes payable 15.7 — 4.3 (20.0 ) — Due to affiliates 2,695.1 — 742.1 (3,437.2 ) — Investment in subsidiaries — 300.9 — (300.9 ) — Operating lease liabilities — 1.8 27.3 — 29.1 Other long-term liabilities 7.4 20.5 6.3 (0.1 ) 34.1 Total non-current liabilities 4,148.7 334.0 856.5 (3,758.2 ) 1,581.0 Total equity (deficit) 252.9 4,400.9 (300.9 ) (4,099.9 ) 253.0 Total liabilities and equity $ 4,443.0 $ 4,894.2 $ 692.1 $ (7,864.0 ) $ 2,165.3
Consolidating Statement of Cash Flows	WELBILT, INC. Consolidating Statement of Cash Flows (Unaudited) (in millions) Three Months Ended March 31, 2020 Parent Guarantor Non- Consolidating Adjustments Consolidated Cash flows from operating activities Net cash (used in) provided by operating activities $ (69.7 ) $ (4.5 ) $ 1.7 $ — $ (72.5 ) Cash flows from investing activities Capital expenditures — (4.5 ) (1.1 ) — (5.6 ) Intercompany investment — 7.6 (7.1 ) (0.5 ) — Other (3.9 ) — — — (3.9 ) Net cash (used in) provided by investing activities (3.9 ) 3.1 (8.2 ) (0.5 ) (9.5 ) Cash flows from financing activities Proceeds from long-term debt 128.0 — — — 128.0 Repayments on long-term debt and finance leases (23.0 ) (0.2 ) (0.1 ) — (23.3 ) Exercises of stock options 1.1 — — — 1.1 Payments on tax withholdings for equity awards (0.7 ) — — — (0.7 ) Intercompany financing (0.5 ) — — 0.5 — Net cash provided by (used in) financing activities 104.9 (0.2 ) (0.1 ) 0.5 105.1 Effect of exchange rate changes on cash — — (5.3 ) — (5.3 ) Net increase (decrease) in cash and cash equivalents and restricted cash 31.3 (1.6 ) (11.9 ) — 17.8 Balance at beginning of period 10.7 0.7 119.3 — 130.7 Balance at end of period $ 42.0 $ (0.9 ) $ 107.4 $ — $ 148.5 WELBILT, INC. Consolidating Statement of Cash Flows (Unaudited) (in millions) Three Months Ended March 31, 2019 Parent Guarantor Non- Consolidating Adjustments Consolidated Cash flows from operating activities Net cash used in operating activities $ (62.5 ) $ (138.2 ) $ (154.0 ) $ (2.3 ) $ (357.0 ) Cash flows from investing activities Cash receipts on beneficial interest in sold receivables — 35.6 160.4 — 196.0 Capital expenditures (1.7 ) (2.4 ) (0.7 ) — (4.8 ) Intercompany investment — 105.6 (8.9 ) (96.7 ) — Other 0.2 — — — 0.2 Net cash (used in) provided by investing activities (1.5 ) 138.8 150.8 (96.7 ) 191.4 Cash flows from financing activities Proceeds from long-term debt 196.5 — — — 196.5 Repayments on long-term debt and finance leases (32.5 ) (0.3 ) — — (32.8 ) Repayment of short-term borrowings — — (15.0 ) — (15.0 ) Payment of contingent consideration — (0.8 ) — — (0.8 ) Exercises of stock options 0.6 — — — 0.6 Payments on tax withholdings for equity awards (1.8 ) — — — (1.8 ) Intercompany financing (96.8 ) — — 96.8 — Net cash provided by (used in) financing activities 66.0 (1.1 ) (15.0 ) 96.8 146.7 Effect of exchange rate changes on cash — — 1.0 — 1.0 Net increase (decrease) in cash and cash equivalents and restricted cash 2.0 (0.5 ) (17.2 ) (2.2 ) (17.9 ) Balance at beginning of period 0.2 0.5 72.5 — 73.2 Balance at end of period $ 2.2 $ — $ 55.3 $ (2.2 ) $ 55.3

Business and Organization (Deta

Business and Organization (Details) distributor in Thousands	3 Months Ended
	Mar. 31, 2020manufacturing_facilitydistributorsegment
Accounting Policies [Abstract]
Number of manufacturing facilities operating globally | manufacturing_facility	20
Number of distributors, dealers, buying groups and manufacturers' representatives (over) | distributor	5
Number of business segments | segment	3

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	Jan. 01, 2020	Jan. 01, 2019	[1]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of accounting standards adoption	$ 0.4	$ (0.2)
Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of accounting standards adoption	0.4	$ (0.2)
Retained Earnings | ASU 2016-13
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of accounting standards adoption	$ 0.4
[1]	Effective January 1, 2019, the Company adopted Accounting Standards Update ("ASU") 2016-02, "Leases (Topic 842)" with additional updates subsequently issued (collectively, "ASU 2016-02"). The cumulative effect of the change made to the Consolidated Statement of Equity as of January 1, 2019 for the adoption of ASU 2016-02 is the result of recognizing the remaining deferred gain associated with a previous sale-leaseback transaction.

Accounts Receivable Securitiz_2

Accounts Receivable Securitization (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 12, 2019
Transfers and Servicing [Abstract]
Capacity of securitization program		$ 110,000,000
Accounts receivable securitization repurchase
Accounts, Notes, Loans and Financing Receivable [Line Items]
Termination of accounts receivable securitization program, reacquired amount	$ 156,900,000
Cash receipts on the reacquired receivables	$ 65,000,000

Inventories - Net (Details)

Inventories - Net (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Inventories — net:
Raw materials	$ 84	$ 81.4
Work-in-process	14.8	14.2
Finished goods	106.3	95
Total inventories at FIFO cost	205.1	190.6
Excess of FIFO costs over LIFO value	(4.2)	(4.2)
Total inventories — net	$ 200.9	$ 186.4

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Net - Changes in the Carrying Amount of Goodwill by Geographic Segment (Details) $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)
Goodwill [Roll Forward]
Beginning gross balance	$ 1,448.8
Beginning accumulated asset impairments	(515.7)
Beginning net balance	933.1
Foreign currency impact	(3.4)
Ending gross balance	1,445.4
Ending accumulated asset impairments	(515.7)
Ending net balance	929.7
Americas
Goodwill [Roll Forward]
Beginning gross balance	1,144.8
Beginning accumulated asset impairments	(312.2)
Beginning net balance	832.6
Foreign currency impact	0
Ending gross balance	1,144.8
Ending accumulated asset impairments	(312.2)
Ending net balance	832.6
EMEA
Goodwill [Roll Forward]
Beginning gross balance	284.1
Beginning accumulated asset impairments	(203.5)
Beginning net balance	80.6
Foreign currency impact	(2.8)
Ending gross balance	281.3
Ending accumulated asset impairments	(203.5)
Ending net balance	77.8
APAC
Goodwill [Roll Forward]
Beginning gross balance	19.9
Beginning accumulated asset impairments	0
Beginning net balance	19.9
Foreign currency impact	(0.6)
Ending gross balance	19.3
Ending accumulated asset impairments	0
Ending net balance	$ 19.3

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Net - Gross Carrying Amount and Accumulated Amortization of Finite-Lived Intangible Assets other than Goodwill (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Intangible asset balances by major asset class
Impairment Charges, finite-lived	$ 0
Impairment Charges, indefinite-lived	(11.1)
Accumulated Amortization Amount, finite-lived	(364)	$ (355.4)
Gross Carrying Amount, Total	857	863.1
Impairment Charges	(11.1)
Net Book Value, Total	481.9	507.7
Customer relationships
Intangible asset balances by major asset class
Gross Carrying Amount, finite-lived	470.7	472.8
Accumulated Amortization Amount, finite-lived	(249.8)	(243.6)
Net Book Value, finite-lived	220.9	229.2
Other intangibles
Intangible asset balances by major asset class
Gross Carrying Amount, finite-lived	165.7	166.9
Accumulated Amortization Amount, finite-lived	(112.2)	(109.8)
Net Book Value, finite-lived	53.5	57.1
Patents
Intangible asset balances by major asset class
Gross Carrying Amount, finite-lived	5.8	5.8
Accumulated Amortization Amount, finite-lived	(2)	(2)
Net Book Value, finite-lived	3.8	3.8
Trademarks and trade names
Intangible asset balances by major asset class
Gross Carrying Amount, indefinite-lived	214.8
Net Book Value, indefinite-lived	$ 203.7	$ 217.6

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Net - Narrative (Details)	3 Months Ended
	Mar. 31, 2020USD ($)
Indefinite-lived Intangible Assets [Line Items]
Impairment Charges, indefinite-lived	$ 11,100,000
EMEA
Indefinite-lived Intangible Assets [Line Items]
Impairment Charges, indefinite-lived	11,100,000
APAC
Indefinite-lived Intangible Assets [Line Items]
Impairment Charges, indefinite-lived	$ 0

Property, Plant and Equipment_3

Property, Plant and Equipment - Net (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment
Total cost	$ 417.5	$ 421.9
Less accumulated depreciation	(292.9)	(294.4)
Total property, plant and equipment — net	124.6	127.5
Land
Property, Plant and Equipment
Total cost	9.6	9.7
Building and improvements
Property, Plant and Equipment
Total cost	92.7	93.2
Machinery, equipment and tooling
Property, Plant and Equipment
Total cost	220.9	223.3
Furniture and fixtures
Property, Plant and Equipment
Total cost	7.4	7.6
Computer hardware and software for internal use
Property, Plant and Equipment
Total cost	65.4	66.1
Construction in progress
Property, Plant and Equipment
Total cost	$ 21.5	$ 22

Accrued Expenses and Other Li_3

Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Payables and Accruals [Abstract]
Accrued rebates and commissions	$ 32.6	$ 56.2
Miscellaneous accrued expenses	34.9	37.8
Employee related expenses	27.9	34.7
Interest payable	5.7	15.8
Operating lease liabilities	10.1	10
Restructuring liabilities	7.4	6.3
Business Transformation Program related expenses	4.1	5.8
Derivative liabilities	1.8	5
Income and other taxes payable	7.7	11.2
Deferred revenues	2.7	3.1
Customer deposits	2.9	3.1
Pension and postretirement health liabilities	2.1	2.1
Product liabilities	1.4	1.3
Total accrued expenses and other liabilities	$ 141.3	$ 192.4

Income Taxes (Details)

Income Taxes (Details) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2020USD ($)segment	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)
Income Tax Disclosure [Abstract]
Income tax provision	$ (0.2)	$ 0.1
Effective tax rate	1.30%	(4.00%)
Discrete tax expense (benefit)	$ 4.6	$ 0.8
Allowable deduction limitation of interest expense	50.00%		30.00%
U.S. federal statutory rate	21.00%	21.00%
Number of reportable segments | segment	3
Unrecognized tax benefits	$ 4.1		$ 4.2
Minimum
Income Tax Contingency [Line Items]
Unrecognized tax benefits reasonably possible to impact effective income tax rate	0.1
Maximum
Income Tax Contingency [Line Items]
Unrecognized tax benefits reasonably possible to impact effective income tax rate	$ 0.5

Debt - Schedule of Outstanding

Debt - Schedule of Outstanding Debt (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Carrying Value, finance leases	$ 2.2	$ 2.5
Total debt and finance leases, including current portion	1,527.1	1,424.3
Less: Term Loan B Facility	(0.8)	0
Less: Current portion of finance leases	(1.1)	(1.2)
Less: Unamortized debt issuance costs	(19.5)	(20.5)
Less: Hedge accounting fair value adjustment	0.4	0.5
Total long-term debt and finance leases	$ 1,506.1	$ 1,403.1
Weighted Average Interest Rate, finance leases	4.83%	4.83%
Debt issuance costs, net of amortization	$ 21.9	$ 23
Debt issuance costs, revolving credit facility	2.4	2.5
Revolving Credit Facility
Debt Instrument [Line Items]
Carrying Value, long-term debt	$ 244.9	$ 141.8
Weighted Average Interest Rate, long-term debt	4.37%	5.00%
Term Loan B Facility
Debt Instrument [Line Items]
Carrying Value, long-term debt	$ 855	$ 855
Weighted Average Interest Rate, long-term debt	4.50%	5.11%
9.50% Senior Notes due 2024
Debt Instrument [Line Items]
Carrying Value, long-term debt	$ 425	$ 425
Stated interest rate	9.50%
Weighted Average Interest Rate, long-term debt	9.72%	9.72%

Debt - Narrative (Details)

Debt - Narrative (Details)	1 Months Ended	3 Months Ended	6 Months Ended
	Apr. 30, 2018USD ($)	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Mar. 31, 2016USD ($)
2016 Credit Facility
Debt Instrument [Line Items]
Balance outstanding				$ 244,900,000	$ 141,800,000
2016 Credit Facility | Line of credit
Debt Instrument [Line Items]
Credit facility capacity						$ 1,300,000,000
2016 Credit Facility | Line of credit | Base Rate
Debt Instrument [Line Items]
Spread on variable interest rate			1.00%
2016 Credit Facility | Line of credit | Term Loan B Facility
Debt Instrument [Line Items]
Credit facility capacity						900,000,000
2016 Credit Facility | Line of credit | Revolving Credit Facility
Debt Instrument [Line Items]
Credit facility capacity						$ 400,000,000
Maximum pro forma senior secured leverage ratio						3.75
Available borrowings				151,000,000
2016 Credit Facility | Line of credit | Revolving Credit Facility | LIBOR
Debt Instrument [Line Items]
Spread on variable interest rate		2.25%
2016 Credit Facility | Line of credit | Revolving Credit Facility | LIBOR | Minimum
Debt Instrument [Line Items]
Spread on variable interest rate			1.50%
2016 Credit Facility | Line of credit | Revolving Credit Facility | LIBOR | Maximum
Debt Instrument [Line Items]
Spread on variable interest rate			2.50%
2016 Credit Facility | Line of credit | Revolving Credit Facility | Base Rate
Debt Instrument [Line Items]
Spread on variable interest rate		1.25%
2016 Credit Facility | Line of credit | Letters of Credit
Debt Instrument [Line Items]
Credit facility capacity						$ 30,000,000
Balance outstanding				4,100,000
2016 Credit Facility | Line of credit | Incremental Revolving or Term Loan Facilities
Debt Instrument [Line Items]
Credit facility capacity						$ 275,000,000
2016 Credit Facility | Term loan | LIBOR
Debt Instrument [Line Items]
Spread on variable interest rate			2.50%
Other Letters of Credit | Other outstanding letters of credit or guarantees of payment | Letters of Credit
Debt Instrument [Line Items]
Balance outstanding				$ 1,300,000
Short-Term Secured Revolving Loan Facility | LIBOR
Debt Instrument [Line Items]
Spread on variable interest rate	1.90%
Short-Term Secured Revolving Loan Facility | Line of credit
Debt Instrument [Line Items]
Credit facility capacity	$ 30,000,000

Derivative Financial Instrume_3

Derivative Financial Instruments - Narrative (Details) € in Millions, $ in Millions	1 Months Ended			3 Months Ended
	Mar. 31, 2020USD ($)	Jun. 30, 2019USD ($)	Mar. 31, 2017EUR (€)swap	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Mar. 31, 2017USD ($)swap
Derivative [Line Items]
Cash flow hedge, gain (loss) to be reclassified in next twelve months				$ (1.1)
Minimum length of time hedged in cash flow hedge				15 months
Maximum length of time hedged in cash flow hedge				36 months
Number of derivative instruments (swap) | swap			2			2
Designated as Hedging Instrument | Interest rate swap contracts
Derivative [Line Items]
Derivative notional amount (USD and EUR)						$ 600
Designated as Hedging Instrument | Cross-currency interest rate swap contract
Derivative [Line Items]
Term of derivative contract			3 years
Derivative notional amount (USD and EUR) | €			€ 50
Payments for derivative instrument	$ 4.1
Interest Rate Swap, March 2020 | Designated as Hedging Instrument | Interest rate swap contracts
Derivative [Line Items]
Derivative notional amount (USD and EUR)	$ 425			$ 425
Proceeds from terminated derivative		$ 14
Interest Rate Swap, March 2019 | Designated as Hedging Instrument | Interest rate swap contracts
Derivative [Line Items]
Derivative notional amount (USD and EUR)					$ 175

Derivative Financial Instrume_4

Derivative Financial Instruments - Schedule of Currency Forward Contracts (Details) - Foreign currency exchange contracts	Mar. 31, 2020MXN ($)	Mar. 31, 2020EUR (€)	Mar. 31, 2020CAD ($)	Mar. 31, 2020SGD ($)	Mar. 31, 2020GBP (£)	Mar. 31, 2020CHF (SFr)	Dec. 31, 2019MXN ($)	Dec. 31, 2019EUR (€)	Dec. 31, 2019CAD ($)	Dec. 31, 2019SGD ($)	Dec. 31, 2019GBP (£)	Dec. 31, 2019CHF (SFr)
Designated as Hedging Instrument
Derivative [Line Items]
Derivative notional amount	$ 65,150,000	€ 4,073,000	$ 4,608,000	$ 1,210,000	£ 4,342,932		$ 111,250,000	€ 7,593,000	$ 8,014,000	$ 2,019,000	£ 8,046,471
Other Operating Income (Expense) | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative notional amount	$ 13,500,000	€ 81,085,000	$ 997,000	$ 28,367,000	£ 26,488,585	SFr 6,400,000	$ 11,805,000	€ 75,557,000	$ 1,330,000	$ 28,427,000	£ 20,323,932	SFr 7,000,000

Derivative Financial Instrume_5

Derivative Financial Instruments - Schedule of Impact of Derivative Instruments on the Consolidated Statements of Comprehensive Income and Consolidated Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Derivative [Line Items]
Pretax gain/(loss) recognized in AOCI	$ (1.1)	$ (0.5)
Pretax gain/(loss) reclassified from AOCI into income	(0.6)	0.7
Foreign currency exchange contracts
Derivative [Line Items]
Pretax gain/(loss) recognized in AOCI	(1.1)	(0.1)
Commodity contracts
Derivative [Line Items]
Pretax gain/(loss) recognized in AOCI	0	0.2
Interest rate swap contracts
Derivative [Line Items]
Pretax gain/(loss) recognized in AOCI	0	(0.6)
Cost of sales | Foreign currency exchange contracts
Derivative [Line Items]
Pretax gain/(loss) reclassified from AOCI into income	(0.1)	(0.3)
Cost of sales | Commodity contracts
Derivative [Line Items]
Pretax gain/(loss) reclassified from AOCI into income	(0.5)	(0.1)
Cost of sales | Interest rate swap contracts
Derivative [Line Items]
Pretax gain/(loss) reclassified from AOCI into income	0	0
Interest expense | Foreign currency exchange contracts
Derivative [Line Items]
Pretax gain/(loss) reclassified from AOCI into income	0	0
Interest expense | Commodity contracts
Derivative [Line Items]
Pretax gain/(loss) reclassified from AOCI into income	0	0
Interest expense | Interest rate swap contracts
Derivative [Line Items]
Pretax gain/(loss) reclassified from AOCI into income	0	1.1
Designated as Hedging Instrument | Net Investment Hedging | Interest rate swap contracts
Derivative [Line Items]
Pretax gain/(loss) recognized in AOCI	(0.8)	1.6
Gain/(loss) reclassified from AOCI into income	0	0
Designated as Hedging Instrument | Net Investment Hedging | Other (income) expense — net | Interest rate swap contracts
Derivative [Line Items]
Gain/(loss) recognized in income (amount excluded from effectiveness testing)	$ 0.3	$ 0.4

Derivative Financial Instrume_6

Derivative Financial Instruments - Effects of Derivative Financial Instruments on Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Cost of Sales	$ 214.1	$ 248.8
Interest Expense	21.3	24
Amount of gain/(loss) reclassified from AOCI into income	(0.6)	0.7
Interest rate contracts | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on hedged item	0	0
Gain (loss) on derivative designated as hedging instrument	0	0
Amount of gain/(loss) reclassified from AOCI into income	0	0
Interest rate contracts | Interest Expense
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on hedged item	0.1	(7)
Gain (loss) on derivative designated as hedging instrument	0	6.6
Amount of gain/(loss) reclassified from AOCI into income	0	1.1
Foreign currency exchange contracts | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) reclassified from AOCI into income	(0.1)	(0.3)
Foreign currency exchange contracts | Interest Expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) reclassified from AOCI into income	0	0
Commodity contracts | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) reclassified from AOCI into income	(0.5)	(0.1)
Commodity contracts | Interest Expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) reclassified from AOCI into income	$ 0	$ 0

Derivative Financial Instrume_7

Derivative Financial Instruments - Schedule of Outstanding Commodity Contracts (Details) - Not Designated as Hedging Instrument	3 Months Ended	12 Months Ended
	Mar. 31, 2020Tt	Dec. 31, 2019Tt
Aluminum
Derivative [Line Items]
Commodity units hedged, mass	392	524
Copper
Derivative [Line Items]
Commodity units hedged, mass	189	269
Steel
Derivative [Line Items]
Commodity units hedged, mass | T	908	1,778

Derivative Financial Instrume_8

Derivative Financial Instruments - Location and Effects on Consolidated Statements of Operations of Derivative Instruments Not Designated as Hedging Instruments (Details) - Not Designated as Hedging Instrument - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) recognized in income on derivative	$ (2.5)	$ 2.8
Foreign currency exchange contracts | Other (income) expense — net
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) recognized in income on derivative	(2)	2.8
Commodity contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) recognized in income on derivative	$ (0.5)	$ 0

Derivative Financial Instrume_9

Derivative Financial Instruments - Schedule of the Fair Value of Outstanding Derivative Contracts Recorded as Assets in the Accompanying Consolidated Balance Sheet (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Total asset derivatives	$ 0.6	$ 1.2
Designated as Hedging Instrument
Derivative [Line Items]
Total asset derivatives	0	0.8
Designated as Hedging Instrument | Prepaids and other current assets | Foreign currency exchange contracts
Derivative [Line Items]
Total asset derivatives	0	0.8
Not Designated as Hedging Instrument
Derivative [Line Items]
Total asset derivatives	0.6	0.4
Not Designated as Hedging Instrument | Prepaids and other current assets | Foreign currency exchange contracts
Derivative [Line Items]
Total asset derivatives	$ 0.6	$ 0.4

Derivative Financial Instrum_10

Derivative Financial Instruments - Schedule of the Fair Value of Outstanding Derivative Contracts Recorded as Liabilities in the Accompanying Consolidated Balance Sheet (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Total liability derivatives	$ 1.8	$ 5
Designated as Hedging Instrument
Derivative [Line Items]
Total liability derivatives	0.8	3.8
Designated as Hedging Instrument | Accrued expenses and other liabilities | Foreign currency exchange contracts
Derivative [Line Items]
Total liability derivatives	0.8	0.6
Designated as Hedging Instrument | Accrued expenses and other liabilities | Interest rate swap contracts
Derivative [Line Items]
Total liability derivatives	0	3.2
Not Designated as Hedging Instrument
Derivative [Line Items]
Total liability derivatives	1	1.2
Not Designated as Hedging Instrument | Accrued expenses and other liabilities | Foreign currency exchange contracts
Derivative [Line Items]
Total liability derivatives	0.3	0.6
Not Designated as Hedging Instrument | Accrued expenses and other liabilities | Commodity contracts
Derivative [Line Items]
Total liability derivatives	$ 0.7	$ 0.6

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Senior Notes
Financial assets and liabilities accounted for at fair value on a recurring basis
Fair value of debt	$ 359.7	$ 450.9
Term Loan B Facility | Secured Debt
Financial assets and liabilities accounted for at fair value on a recurring basis
Fair value of debt	$ 671.7	$ 860.9

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Financial Assets and Liabilities Accounted for at Fair Value on a Recurring Basis by Level within the Fair Value Hierarchy (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current assets at fair value	$ 0.6	$ 1.2
Total assets at fair value	0.6	1.2
Total current liabilities at fair value	1.8	5
Total liabilities at fair value	1.8	5
Foreign currency exchange contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Derivative assets, current	0.6	1.2
Total current liabilities at fair value	1.1	1.2
Commodity contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current liabilities at fair value	0.7	0.6
Interest rate swap contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current liabilities at fair value		3.2
Level 1
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current assets at fair value	0	0
Total assets at fair value	0	0
Total current liabilities at fair value	0	0
Total liabilities at fair value	0	0
Level 1 | Foreign currency exchange contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Derivative assets, current	0	0
Total current liabilities at fair value	0	0
Level 1 | Commodity contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current liabilities at fair value	0	0
Level 1 | Interest rate swap contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current liabilities at fair value		0
Level 2
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current assets at fair value	0.6	1.2
Total assets at fair value	0.6	1.2
Total current liabilities at fair value	1.8	5
Total liabilities at fair value	1.8	5
Level 2 | Foreign currency exchange contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Derivative assets, current	0.6	1.2
Total current liabilities at fair value	1.1	1.2
Level 2 | Commodity contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current liabilities at fair value	0.7	0.6
Level 2 | Interest rate swap contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current liabilities at fair value		3.2
Level 3
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current assets at fair value	0	0
Total assets at fair value	0	0
Total current liabilities at fair value	0	0
Total liabilities at fair value	0	0
Level 3 | Foreign currency exchange contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Derivative assets, current	0	0
Total current liabilities at fair value	0	0
Level 3 | Commodity contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current liabilities at fair value	$ 0	0
Level 3 | Interest rate swap contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current liabilities at fair value		$ 0

Contingencies and Significant_2

Contingencies and Significant Estimates (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Product Warranty Liability [Line Items]
Warranty claims expected to be paid	$ 42	$ 43.9
Self-insured retention level for commercial general liability	2
Product liability reserves	1.4	1.3
Product liability reserves for specific cases	0.8	0.7
Product liability reserves for claims incurred but not reported	0.6	0.6
Reserve for environmental matters	0.7	$ 0.7
Estimate of possible loss	3.1
United States
Product Warranty Liability [Line Items]
Self-insured retention level per occurrence	0.3
Self-insured retention level in the aggregate	1
Canada
Product Warranty Liability [Line Items]
Self-insured retention level per occurrence	0.1
Self-insured retention level in the aggregate	2
Minimum
Product Warranty Liability [Line Items]
Estimate of possible loss	3.1
Maximum
Product Warranty Liability [Line Items]
Estimate of possible loss	$ 9

Product Warranties - Narrative

Product Warranties - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Product Warranty Liability [Line Items]
Standard product warranty period, low end of range	12 months
Standard product warranty period, high end of range	60 months
Short-term portion of deferred revenue	$ 2.7	$ 3.1
Accrued expenses and other liabilities
Product Warranty Liability [Line Items]
Short-term portion of deferred revenue	1.8	1.8
Other long-term liabilities
Product Warranty Liability [Line Items]
Long-term portion of deferred revenue	$ 3.7	$ 3.8

Product Warranties - Schedule o

Product Warranties - Schedule of the Summary of Product Warranty Activity (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Warranty activity
Balance at beginning of period	$ 43.9
Additions for issuance of warranties	8.4
Settlements (in cash or in kind)	(9.5)
Currency translation impact	(0.8)
Balance at end of period	42
Other long-term liabilities
Product Warranty Liability [Line Items]
Long-term product warranty liabilities	$ 10.1	$ 10.6

Employee Benefit Plans - Compon

Employee Benefit Plans - Components of Period Benefits Costs (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Interest cost of projected benefit obligations	$ 1	$ 1.3
Expected return on assets	(1)	(1.2)
Amortization of prior service cost	0	0
Amortization of actuarial net loss	0.6	0.5
Settlement loss recognized	0	1.2
Net periodic benefit cost	0.6	1.8
Postretirement Health Plans
Defined Benefit Plan Disclosure [Line Items]
Interest cost of projected benefit obligations	0	0.1
Expected return on assets	0	0
Amortization of prior service cost	(0.1)	0
Amortization of actuarial net loss	0.2	0.1
Settlement loss recognized	0	0
Net periodic benefit cost	$ 0.1	$ 0.2

Employee Benefit Plans - Narrat

Employee Benefit Plans - Narrative (Details) - Pension Plans - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Defined Benefit Plan Disclosure [Line Items]
Reduction in accrued pension obligations		$ 5.5
Non-cash loss for accelerated recognition of unamortized losses	$ 0	$ 1.2

Business Transformation Progr_3

Business Transformation Program and Restructuring - Transformation Program Expense (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Schedule Of Business Transformation Program Costs [Line Items]
Transformation Program expense	$ 11.6	$ 5.8
Cost of sales
Schedule Of Business Transformation Program Costs [Line Items]
Transformation Program expense	0.8	0
Selling, general and administrative expenses
Schedule Of Business Transformation Program Costs [Line Items]
Transformation Program expense	$ 10.8	$ 5.8

Business Transformation Progr_4

Business Transformation Program and Restructuring - Rollforward of all Restructuring Activities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019
Rollforward of all restructuring activities
Beginning balance	$ 14.9
Restructuring activities	3.7		$ 4.2
Cash payments	(2.7)
Non-cash adjustments	(0.2)
Ending balance	15.7
Workforce reductions
Rollforward of all restructuring activities
Restructuring activities		$ 1.2	$ 4.2
Workforce reductions | 2020 Plans
Rollforward of all restructuring activities
Beginning balance	0
Restructuring activities	2.8
Cash payments	(0.4)
Non-cash adjustments	(0.1)
Ending balance	2.3
Workforce reductions | 2019 and Previous Plans
Rollforward of all restructuring activities
Beginning balance	5
Restructuring activities	0.8
Cash payments	(2)
Non-cash adjustments	0
Ending balance	3.8
Other | 2020 Plans
Rollforward of all restructuring activities
Beginning balance	0
Restructuring activities	0.1
Cash payments	0
Non-cash adjustments	(0.1)
Ending balance	0
Pension withdrawal obligation | 2019 and Previous Plans
Rollforward of all restructuring activities
Beginning balance	9.9
Restructuring activities	0
Cash payments	(0.3)
Non-cash adjustments	0
Ending balance	$ 9.6

Business Transformation Progr_5

Business Transformation Program and Restructuring - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2019
Restructuring Cost and Reserve [Line Items]
Current portion of liability	$ 7.4			$ 6.3
Long term-portion of liability	8.3			$ 8.6
Restructuring activities	3.7		$ 4.2
Workforce reductions
Restructuring Cost and Reserve [Line Items]
Restructuring activities		$ 1.2	4.2
Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring activities	0.7		2
Americas | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring activities	2.2		$ 1.7
2020 Plans | Workforce reductions
Restructuring Cost and Reserve [Line Items]
Expected cost	4
Restructuring activities	2.8
Expected cost remaining	1.2
2020 Plans | Corporate | Workforce reductions
Restructuring Cost and Reserve [Line Items]
Expected cost	1.8
Restructuring activities	0.6
2020 Plans | Americas | Operating Segments | Workforce reductions
Restructuring Cost and Reserve [Line Items]
Expected cost	2.2
Restructuring activities	2.2
2019 and Previous Plans | Workforce reductions
Restructuring Cost and Reserve [Line Items]
Restructuring activities	0.8
Expected cost remaining	$ 1.3

Business Transformation Progr_6

Business Transformation Program and Restructuring - Restructuring Expense by Segment (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Restructuring Cost and Reserve [Line Items]
Restructuring activities	$ 3.7	$ 4.2
Cost of sales
Restructuring Cost and Reserve [Line Items]
Restructuring activities	0.1	0
Restructuring and other expenses
Restructuring Cost and Reserve [Line Items]
Restructuring activities	3.6	4.2
Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring activities	0.7	2
Americas | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring activities	2.2	1.7
EMEA | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring activities	0.3	0.4
APAC | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring activities	$ 0.5	$ 0.1

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss - Components of AOCI (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total accumulated other comprehensive loss	$ 213	$ 253	$ 185.3	$ 186.4
Foreign Currency Translation
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total accumulated other comprehensive loss	(32.5)	(4.3)	(6.5)	(6.5)
Tax expense (benefit)	(0.9)	(1.6)
Gains and Losses on Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total accumulated other comprehensive loss	(2)	(1.6)	(0.2)	0.8
Tax expense (benefit)	0.7	0.8
Pension & Postretirement
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total accumulated other comprehensive loss	(33.6)	(35.6)	(37.1)	(35.9)
Tax expense (benefit)	(6.4)	(6.5)
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total accumulated other comprehensive loss	$ (68.1)	$ (41.5)	$ (43.8)	$ (41.6)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss - Reconciliations for the Changes in AOCI (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 253	$ 186.4
Other comprehensive (loss) income before reclassifications	(27.2)	(3.1)
Reclassifications	1.3	1.1
Tax effect	(0.7)	(0.2)
Total other comprehensive loss, net of tax	(26.6)	(2.2)
Ending balance	213	185.3
Foreign Currency Translation
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(4.3)	(6.5)
Other comprehensive (loss) income before reclassifications	(27.5)	0.3
Reclassifications	0	0
Tax effect	(0.7)	(0.3)
Total other comprehensive loss, net of tax	(28.2)	0
Ending balance	(32.5)	(6.5)
Gains and Losses on Cash Flow Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(1.6)	0.8
Other comprehensive (loss) income before reclassifications	(1.1)	(0.5)
Reclassifications	0.6	(0.7)
Tax effect	0.1	0.2
Total other comprehensive loss, net of tax	(0.4)	(1)
Ending balance	(2)	(0.2)
Pension & Postretirement
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(35.6)	(35.9)
Other comprehensive (loss) income before reclassifications	1.4	(2.9)
Reclassifications	0.7	1.8
Tax effect	(0.1)	(0.1)
Total other comprehensive loss, net of tax	2	(1.2)
Ending balance	(33.6)	(37.1)
Total
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(41.5)	(41.6)
Total other comprehensive loss, net of tax	(26.6)	(2.2)
Ending balance	$ (68.1)	$ (43.8)

Accumulated Other Comprehensi_5

Accumulated Other Comprehensive Loss - Reclassifications (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	$ 214.1	$ 248.8
Interest expense	21.3	24
Loss before income taxes	(15.3)	(2.5)
Tax effect	0.2	(0.1)
Net loss	(15.1)	(2.6)
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net loss	(1.1)	(0.9)
Reclassification out of Accumulated Other Comprehensive Income | Gains (losses) on cash flow hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest expense	0	1.1
Loss before income taxes	(0.6)	0.7
Tax effect	0.1	0.1
Net loss	(0.5)	0.8
Reclassification out of Accumulated Other Comprehensive Income | Amortization of prior service cost
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Loss before income taxes	0.1	0
Reclassification out of Accumulated Other Comprehensive Income | Actuarial losses
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Loss before income taxes	(0.8)	(0.6)
Reclassification out of Accumulated Other Comprehensive Income | Pension settlement
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Loss before income taxes	0	(1.2)
Reclassification out of Accumulated Other Comprehensive Income | Amortization of pension and postretirement items
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Loss before income taxes	(0.7)	(1.8)
Tax effect	0.1	0.1
Net loss	(0.6)	(1.7)
Reclassification out of Accumulated Other Comprehensive Income | Foreign currency exchange contracts | Gains (losses) on cash flow hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	(0.1)	(0.3)
Reclassification out of Accumulated Other Comprehensive Income | Commodity contracts | Gains (losses) on cash flow hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	$ (0.5)	$ (0.1)

Loss Per Share - Antidilutive S

Loss Per Share - Antidilutive Shares (Details) - shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potential shares of common stock	3,639,747	3,288,680
Performance target achievement (in percent)	100.00%
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potential shares of common stock	2,372,495	2,232,634
Unvested restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potential shares of common stock	575,758	438,978
Unvested performance share units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potential shares of common stock	691,494	617,068
Vesting period	3 years
Unvested performance share units | Minimum
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Vesting percentage	0.00%
Unvested performance share units | Maximum
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Vesting percentage	200.00%

Business Segments - Financial I

Business Segments - Financial Information by Segment (Details) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2020USD ($)segment	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)
Segment Reporting Information [Line Items]
Number of business segments | segment	3
Total net sales	$ 328.9	$ 375.3
Segment Adjusted Operating EBITDA:
Amortization expense	(10)	(9.5)
Depreciation expense	(5.2)	(4.9)
Transaction costs	(0.1)	(0.4)
Other items	(3.1)	(0.8)
Transformation Program expense	(11.6)	(5.8)
Restructuring activities	(3.7)	(4.2)
Loss from impairment and disposal of assets — net	(11.2)	0
Earnings from operations	0.6	24.5
Interest expense	(21.3)	(24)
Other income (expense) — net	5.4	(3)
Loss before income taxes	(15.3)	(2.5)
Fair value inventory adjustments		0.2
Professional services and other direct acquisition and integration costs	0.1	0.2
Operating Segments
Segment Adjusted Operating EBITDA:
Total Segment Adjusted Operating EBITDA	74.1	70.6
Elimination of intersegment sales
Segment Reporting Information [Line Items]
Total net sales	(62.9)		$ (61.3)
Corporate and unallocated expenses
Segment Adjusted Operating EBITDA:
Total Segment Adjusted Operating EBITDA	(28.6)	(20.5)
Americas
Segment Reporting Information [Line Items]
Total net sales	218.1	240.8
Americas | Operating Segments
Segment Reporting Information [Line Items]
Total net sales	250.5	275.1
Segment Adjusted Operating EBITDA:
Total Segment Adjusted Operating EBITDA	$ 52.3	$ 44.5
Americas | Operating Segments | Geographic Concentration Risk | EBITDA
Segment Adjusted Operating EBITDA:
Adjusted Operating EBITDA % by segment	20.90%	16.20%
EMEA
Segment Reporting Information [Line Items]
Total net sales	$ 71.6	$ 90.9
EMEA | Operating Segments
Segment Reporting Information [Line Items]
Total net sales	90	106.7
Segment Adjusted Operating EBITDA:
Total Segment Adjusted Operating EBITDA	$ 13.6	$ 18.2
EMEA | Operating Segments | Geographic Concentration Risk | EBITDA
Segment Adjusted Operating EBITDA:
Adjusted Operating EBITDA % by segment	15.10%	17.10%
APAC
Segment Reporting Information [Line Items]
Total net sales	$ 39.2	$ 43.6
APAC | Operating Segments
Segment Reporting Information [Line Items]
Total net sales	51.3	54.8
Segment Adjusted Operating EBITDA:
Total Segment Adjusted Operating EBITDA	$ 8.2	$ 7.9
APAC | Operating Segments | Geographic Concentration Risk | EBITDA
Segment Adjusted Operating EBITDA:
Adjusted Operating EBITDA % by segment	16.00%	14.40%

Business Segments - Revenue by

Business Segments - Revenue by Major Source and Geographic Location (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Disaggregation of Revenue [Line Items]
Total net sales	$ 328.9	$ 375.3
Commercial Foodservice Equipment
Disaggregation of Revenue [Line Items]
Total net sales	270	316.1
Aftermarket Parts and Support
Disaggregation of Revenue [Line Items]
Total net sales	58.9	59.2
Americas
Disaggregation of Revenue [Line Items]
Total net sales	218.1	240.8
Americas | Commercial Foodservice Equipment
Disaggregation of Revenue [Line Items]
Total net sales	182	202.6
Americas | Aftermarket Parts and Support
Disaggregation of Revenue [Line Items]
Total net sales	36.1	38.2
EMEA
Disaggregation of Revenue [Line Items]
Total net sales	71.6	90.9
EMEA | Commercial Foodservice Equipment
Disaggregation of Revenue [Line Items]
Total net sales	56	77.5
EMEA | Aftermarket Parts and Support
Disaggregation of Revenue [Line Items]
Total net sales	15.6	13.4
APAC
Disaggregation of Revenue [Line Items]
Total net sales	39.2	43.6
APAC | Commercial Foodservice Equipment
Disaggregation of Revenue [Line Items]
Total net sales	32	36
APAC | Aftermarket Parts and Support
Disaggregation of Revenue [Line Items]
Total net sales	7.2	7.6
United States
Disaggregation of Revenue [Line Items]
Total net sales	204.4	225
Other Americas
Disaggregation of Revenue [Line Items]
Total net sales	18.5	20.3
EMEA
Disaggregation of Revenue [Line Items]
Total net sales	69.2	88.6
APAC
Disaggregation of Revenue [Line Items]
Total net sales	$ 36.8	$ 41.4

Business Segments - Total Asset

Business Segments - Total Assets by Segment (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Total assets	$ 2,185	$ 2,165.3
Operating Segments | Americas
Segment Reporting Information [Line Items]
Total assets	1,529.1	1,528
Operating Segments | EMEA
Segment Reporting Information [Line Items]
Total assets	336	349.8
Operating Segments | APAC
Segment Reporting Information [Line Items]
Total assets	202.3	211.8
Corporate
Segment Reporting Information [Line Items]
Total assets	$ 117.6	$ 75.7

Subsidiary Guarantors and Sen_3

Subsidiary Guarantors and Senior Notes - Statement of Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Condensed Income Statements, Captions [Line Items]
Total net sales	$ 328.9	$ 375.3
Cost of sales	214.1	248.8
Gross profit	114.8	126.5
Selling, general and administrative expenses	86.5	88.3
Amortization expense	9.7	9.5
Restructuring and other expenses	6.8	4.2
Loss from impairment and disposal of assets — net	11.2	0
Earnings from operations	0.6	24.5
Interest expense	21.3	24
Other (income) expense — net	(5.4)	3
Equity in earnings of subsidiaries	0	0
Loss before income taxes	(15.3)	(2.5)
Income taxes	(0.2)	0.1
Net loss	(15.1)	(2.6)
Total other comprehensive loss, net of tax	(26.6)	(2.2)
Comprehensive loss	(41.7)	(4.8)
Reportable Legal Entities | Parent
Condensed Income Statements, Captions [Line Items]
Total net sales	0	0
Cost of sales	0	1
Gross profit	0	(1)
Selling, general and administrative expenses	18.1	20.6
Amortization expense	0	0
Restructuring and other expenses	0.7	1.5
Loss from impairment and disposal of assets — net	0
Earnings from operations	(18.8)	(23.1)
Interest expense	20.8	21.8
Other (income) expense — net	(4.1)	(6.4)
Equity in earnings of subsidiaries	5	27.1
Loss before income taxes	(30.5)	(11.4)
Income taxes	(15.4)	(8.8)
Net loss	(15.1)	(2.6)
Total other comprehensive loss, net of tax	(26.6)	(2.2)
Comprehensive loss	(41.7)	(4.8)
Reportable Legal Entities | Guarantor Subsidiaries
Condensed Income Statements, Captions [Line Items]
Total net sales	233.1	247.2
Cost of sales	170	188.6
Gross profit	63.1	58.6
Selling, general and administrative expenses	32.8	35.3
Amortization expense	7.1	7.1
Restructuring and other expenses	4.8	1.3
Loss from impairment and disposal of assets — net	0
Earnings from operations	18.4	14.9
Interest expense	0.2	0.2
Other (income) expense — net	(6.3)	(0.7)
Equity in earnings of subsidiaries	(4.4)	14.8
Loss before income taxes	20.1	30.2
Income taxes	15.1	3.1
Net loss	5	27.1
Total other comprehensive loss, net of tax	(25)	(30.5)
Comprehensive loss	(20)	(3.4)
Reportable Legal Entities | Non- Guarantor Subsidiaries
Condensed Income Statements, Captions [Line Items]
Total net sales	210.9	231
Cost of sales	159.2	162.1
Gross profit	51.7	68.9
Selling, general and administrative expenses	35.6	32.4
Amortization expense	2.6	2.4
Restructuring and other expenses	1.3	1.4
Loss from impairment and disposal of assets — net	11.2
Earnings from operations	1	32.7
Interest expense	0.3	2
Other (income) expense — net	5	10.1
Equity in earnings of subsidiaries	0	0
Loss before income taxes	(4.3)	20.6
Income taxes	0.1	5.8
Net loss	(4.4)	14.8
Total other comprehensive loss, net of tax	(24.6)	(28.5)
Comprehensive loss	(29)	(13.7)
Consolidating Adjustments
Condensed Income Statements, Captions [Line Items]
Total net sales	(115.1)	(102.9)
Cost of sales	(115.1)	(102.9)
Gross profit	0	0
Selling, general and administrative expenses	0	0
Amortization expense	0	0
Restructuring and other expenses	0	0
Loss from impairment and disposal of assets — net	0
Earnings from operations	0	0
Interest expense	0	0
Other (income) expense — net	0	0
Equity in earnings of subsidiaries	(0.6)	(41.9)
Loss before income taxes	(0.6)	(41.9)
Income taxes	0	0
Net loss	(0.6)	(41.9)
Total other comprehensive loss, net of tax	49.6	59
Comprehensive loss	$ 49	$ 17.1

Subsidiary Guarantors and Sen_4

Subsidiary Guarantors and Senior Notes - Balance Sheets (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 148.5	$ 130.7
Accounts receivable — net	190	183.6
Intercompany trade receivable		0
Inventories — net	200.9	186.4
Prepaids and other current assets	46.5	28.2
Total current assets	585.9	528.9
Property, plant and equipment — net	124.6	127.5
Operating lease right-of-use assets	38.3	39.9
Goodwill	929.7	933.1
Other intangible assets — net	481.9	507.7
Intercompany long-term notes receivable	0	0
Due from affiliates	0	0
Investment in subsidiaries	0	0
Other non-current assets	24.6	28.2
Total assets	2,185	2,165.3
Current liabilities:
Trade accounts payable	113.8	104.4
Accrued expenses and other liabilities	141.3	192.4
Current portion of long-term debt and finance leases	1.9	1.2
Intercompany trade payable		0
Product warranties	31.9	33.3
Total current liabilities	288.9	331.3
Total long-term debt and finance leases	1,506.1	1,403.1
Deferred income taxes	87.1	81.9
Pension and postretirement health liabilities	30.4	32.8
Intercompany long-term notes payable	0	0
Due to affiliates	0	0
Investment in subsidiaries	0	0
Operating lease liabilities	27.5	29.1
Other long-term liabilities	32	34.1
Total non-current liabilities	1,683.1	1,581
Total equity (deficit)	213	253	$ 185.3	$ 186.4
Total liabilities and equity	2,185	2,165.3
Reportable Legal Entities | Parent
Current assets:
Cash and cash equivalents	42	10.7
Accounts receivable — net	0	0.1
Intercompany trade receivable		0
Inventories — net	0	0
Prepaids and other current assets	24.5	6.7
Total current assets	66.5	17.5
Property, plant and equipment — net	14.3	17
Operating lease right-of-use assets	0.1	0
Goodwill	0	0
Other intangible assets — net	0.2	0
Intercompany long-term notes receivable	0	0
Due from affiliates	0	0
Investment in subsidiaries	4,406	4,400.9
Other non-current assets	4.9	7.6
Total assets	4,492	4,443
Current liabilities:
Trade accounts payable	0.3	0.2
Accrued expenses and other liabilities	20.2	35.3
Current portion of long-term debt and finance leases	0.9	0
Intercompany trade payable		5.9
Product warranties	0	0
Total current liabilities	21.4	41.4
Total long-term debt and finance leases	1,475.2	1,370
Deferred income taxes	51.1	45
Pension and postretirement health liabilities	14.9	15.5
Intercompany long-term notes payable	15.6	15.7
Due to affiliates	2,694.6	2,695.1
Investment in subsidiaries	0	0
Operating lease liabilities	0	0
Other long-term liabilities	6.3	7.4
Total non-current liabilities	4,257.7	4,148.7
Total equity (deficit)	212.9	252.9
Total liabilities and equity	4,492	4,443
Reportable Legal Entities | Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	(0.9)	0.7
Accounts receivable — net	81.8	82.5
Intercompany trade receivable		5.9
Inventories — net	108.8	100.2
Prepaids and other current assets	3.7	6.8
Total current assets	193.4	196.1
Property, plant and equipment — net	70	66.4
Operating lease right-of-use assets	4.7	3.6
Goodwill	832.4	832.4
Other intangible assets — net	337	344.2
Intercompany long-term notes receivable	10.1	10.1
Due from affiliates	3,429.7	3,437.2
Investment in subsidiaries	0	0
Other non-current assets	3.8	4.2
Total assets	4,881.1	4,894.2
Current liabilities:
Trade accounts payable	52.8	49
Accrued expenses and other liabilities	63.1	87.7
Current portion of long-term debt and finance leases	0.6	0.7
Intercompany trade payable		0
Product warranties	20.7	21.9
Total current liabilities	137.2	159.3
Total long-term debt and finance leases	0.6	0.6
Deferred income taxes	0	0
Pension and postretirement health liabilities	10.1	10.2
Intercompany long-term notes payable	0	0
Due to affiliates	0	0
Investment in subsidiaries	305.2	300.9
Operating lease liabilities	2.3	1.8
Other long-term liabilities	19.7	20.5
Total non-current liabilities	337.9	334
Total equity (deficit)	4,406	4,400.9
Total liabilities and equity	4,881.1	4,894.2
Reportable Legal Entities | Non- Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	107.4	119.3
Accounts receivable — net	108.2	101
Intercompany trade receivable		0
Inventories — net	92.1	86.2
Prepaids and other current assets	18.3	14.7
Total current assets	326	321.2
Property, plant and equipment — net	40.3	44.1
Operating lease right-of-use assets	33.5	36.3
Goodwill	97.3	100.7
Other intangible assets — net	144.7	163.5
Intercompany long-term notes receivable	9.9	9.9
Due from affiliates	0	0
Investment in subsidiaries	0	0
Other non-current assets	15.9	16.4
Total assets	667.6	692.1
Current liabilities:
Trade accounts payable	60.7	55.2
Accrued expenses and other liabilities	58	69.4
Current portion of long-term debt and finance leases	0.4	0.5
Intercompany trade payable		0
Product warranties	11.2	11.4
Total current liabilities	130.3	136.5
Total long-term debt and finance leases	30.3	32.5
Deferred income taxes	36	36.9
Pension and postretirement health liabilities	5.4	7.1
Intercompany long-term notes payable	4.6	4.3
Due to affiliates	735	742.1
Investment in subsidiaries	0	0
Operating lease liabilities	25.2	27.3
Other long-term liabilities	6	6.3
Total non-current liabilities	842.5	856.5
Total equity (deficit)	(305.2)	(300.9)
Total liabilities and equity	667.6	692.1
Consolidating Adjustments
Current assets:
Cash and cash equivalents	0	0
Accounts receivable — net	0	0
Intercompany trade receivable		(5.9)
Inventories — net	0	0
Prepaids and other current assets	0	0
Total current assets	0	(5.9)
Property, plant and equipment — net	0	0
Operating lease right-of-use assets	0	0
Goodwill	0	0
Other intangible assets — net	0	0
Intercompany long-term notes receivable	(20)	(20)
Due from affiliates	(3,429.7)	(3,437.2)
Investment in subsidiaries	(4,406)	(4,400.9)
Other non-current assets	0	0
Total assets	(7,855.7)	(7,864)
Current liabilities:
Trade accounts payable	0	0
Accrued expenses and other liabilities	0	0
Current portion of long-term debt and finance leases	0	0
Intercompany trade payable		(5.9)
Product warranties	0	0
Total current liabilities	0	(5.9)
Total long-term debt and finance leases	0	0
Deferred income taxes	0	0
Pension and postretirement health liabilities	0	0
Intercompany long-term notes payable	(20.2)	(20)
Due to affiliates	(3,429.6)	(3,437.2)
Investment in subsidiaries	(305.2)	(300.9)
Operating lease liabilities	0	0
Other long-term liabilities	0	(0.1)
Total non-current liabilities	(3,755)	(3,758.2)
Total equity (deficit)	(4,100.7)	(4,099.9)
Total liabilities and equity	$ (7,855.7)	$ (7,864)

Subsidiary Guarantors and Sen_5

Subsidiary Guarantors and Senior Notes - Cash Flows (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Condensed Cash Flow Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	$ (72.5)	$ (357)
Cash flows from investing activities
Cash receipts on beneficial interest in sold receivables	0	196
Capital expenditures	(5.6)	(4.8)
Intercompany investment	0	0
Other	(3.9)	0.2
Net cash (used in) provided by investing activities	(9.5)	191.4
Cash flows from financing activities
Proceeds from long-term debt	128	196.5
Repayments on long-term debt and finance leases	(23.3)	(32.8)
Repayment of short-term borrowings	0	(15)
Payment of contingent consideration	0	(0.8)
Exercises of stock options	1.1	0.6
Payments on tax withholdings for equity awards	(0.7)	(1.8)
Intercompany financing	0	0
Net cash provided by financing activities	105.1	146.7
Effect of exchange rate changes on cash	(5.3)	1
Net increase (decrease) in cash and cash equivalents and restricted cash	17.8	(17.9)
Balance at beginning of period	130.7	73.2
Balance at end of period	148.5	55.3
Reportable Legal Entities | Parent
Condensed Cash Flow Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(69.7)	(62.5)
Cash flows from investing activities
Cash receipts on beneficial interest in sold receivables		0
Capital expenditures	0	(1.7)
Intercompany investment	0	0
Other	(3.9)	0.2
Net cash (used in) provided by investing activities	(3.9)	(1.5)
Cash flows from financing activities
Proceeds from long-term debt	128	196.5
Repayments on long-term debt and finance leases	(23)	(32.5)
Repayment of short-term borrowings		0
Payment of contingent consideration		0
Exercises of stock options	1.1	0.6
Payments on tax withholdings for equity awards	(0.7)	(1.8)
Intercompany financing	(0.5)	(96.8)
Net cash provided by financing activities	104.9	66
Effect of exchange rate changes on cash	0	0
Net increase (decrease) in cash and cash equivalents and restricted cash	31.3	2
Balance at beginning of period	10.7	0.2
Balance at end of period	42	2.2
Reportable Legal Entities | Guarantor Subsidiaries
Condensed Cash Flow Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(4.5)	(138.2)
Cash flows from investing activities
Cash receipts on beneficial interest in sold receivables		35.6
Capital expenditures	(4.5)	(2.4)
Intercompany investment	7.6	105.6
Other	0	0
Net cash (used in) provided by investing activities	3.1	138.8
Cash flows from financing activities
Proceeds from long-term debt	0	0
Repayments on long-term debt and finance leases	(0.2)	(0.3)
Repayment of short-term borrowings		0
Payment of contingent consideration		(0.8)
Exercises of stock options	0	0
Payments on tax withholdings for equity awards	0	0
Intercompany financing	0	0
Net cash provided by financing activities	(0.2)	(1.1)
Effect of exchange rate changes on cash	0	0
Net increase (decrease) in cash and cash equivalents and restricted cash	(1.6)	(0.5)
Balance at beginning of period	0.7	0.5
Balance at end of period	(0.9)	0
Reportable Legal Entities | Non- Guarantor Subsidiaries
Condensed Cash Flow Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	1.7	(154)
Cash flows from investing activities
Cash receipts on beneficial interest in sold receivables		160.4
Capital expenditures	(1.1)	(0.7)
Intercompany investment	(7.1)	(8.9)
Other	0	0
Net cash (used in) provided by investing activities	(8.2)	150.8
Cash flows from financing activities
Proceeds from long-term debt	0	0
Repayments on long-term debt and finance leases	(0.1)	0
Repayment of short-term borrowings		(15)
Payment of contingent consideration		0
Exercises of stock options	0	0
Payments on tax withholdings for equity awards	0	0
Intercompany financing	0	0
Net cash provided by financing activities	(0.1)	(15)
Effect of exchange rate changes on cash	(5.3)	1
Net increase (decrease) in cash and cash equivalents and restricted cash	(11.9)	(17.2)
Balance at beginning of period	119.3	72.5
Balance at end of period	107.4	55.3
Consolidating Adjustments
Condensed Cash Flow Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	(2.3)
Cash flows from investing activities
Cash receipts on beneficial interest in sold receivables		0
Capital expenditures	0	0
Intercompany investment	(0.5)	(96.7)
Other	0	0
Net cash (used in) provided by investing activities	(0.5)	(96.7)
Cash flows from financing activities
Proceeds from long-term debt	0	0
Repayments on long-term debt and finance leases	0	0
Repayment of short-term borrowings		0
Payment of contingent consideration		0
Exercises of stock options	0	0
Payments on tax withholdings for equity awards	0	0
Intercompany financing	0.5	96.8
Net cash provided by financing activities	0.5	96.8
Effect of exchange rate changes on cash	0	0
Net increase (decrease) in cash and cash equivalents and restricted cash	0	(2.2)
Balance at beginning of period	0	0
Balance at end of period	$ 0	$ (2.2)

Subsequent Event (Details)

Subsequent Event (Details) - Line of credit - Amended 2016 Credit Agreement - Revolving Credit Facility - Subsequent Event	Apr. 17, 2020USD ($)
Subsequent Event [Line Items]
Term to comply with financial covenants	90 days
Cash balance limit	$ 100,000,000
Term to use cash in excess of draw restriction	10 days
Carve-out restriction for general investments	$ 25,000,000
Quarterly fee	0.50%
Debt issuance cost	$ 2,300,000